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As doenças alérgicas são consideradas uma das epidemias do século XXI, afectando 
aproximadamente um terço da população em geral. De entre as fontes alergénicas ambientais 
capazes de induzir reacções de hipersensibilidade de tipo I, os fungos têm sido uma das áreas 
de estudo menos favorecidas. No entanto, a sensibilização a aero-alergénios de origem 
fúngica tem sido apontada por vários autores como um factor de risco indiscutível para o 
desenvolvimento, persistência e severidade de doença alérgica respiratória, nomeadamente 
da asma. Estes dados sugerem que a realização de estudos visando progressos, 
nomeadamente, nos métodos de detecção de exposição ambiental, assim como nas 
metodologias de diagnóstico, são necessários e cruciais para a melhor compreensão, 
diagnóstico e tratamento das doenças alérgicas provocadas por espécies fúngicas. 
Os métodos de avaliação de contaminação ambiental por fungos de importância alergológica, 
tradicionalmente usados em estudos epidemiológicos e aerobiológicos, têm como base a 
detecção e identificação de espécies por observação microscópica de características 
morfológicas e contagem de esporos. Na sua generalidade, a execução destes métodos é 
bastante demorada, complexa e requer a presença de pessoal treinado com elevados 
conhecimentos na área da micologia. Desta forma, a definição ou exclusão de contaminação 
ambiental por uma determinada espécie fúngica e a associação de exposição com um padrão 
de sintomatologia alérgica tem sido bastante problemática. Em termos de diagnóstico, a 
principal dificuldade atual resulta do grande número de doentes que estão aparentemente 
sensibilizados a mais do que uma espécie fúngica. Nestes casos clínicos, o diagnóstico da 
causa primária de sensibilização é bastante complexo. 
Vários estudos epidemiológicos realizados, fundamentalmente na Europa, têm descrito 
Alternaria alternata como a fonte de aero-alergénios de origem fúngica mais importante e 
com maior alergenicidade. Tais relatos sugerem que o estudo do painel de alergénios 
produzidos por esta espécie pode ser um alvo de estudo que pode contribuir para o avanço 
significativo na área de conhecimento das alergias a fungos. Entre as várias proteínas 
alergénicas descritas até ao momento, Alt a 1, constitui o alergénio de A. alternata mais 
importante, sendo responsável pela sensibilização de, pelo menos, 80% dos doentes 
diagnosticados como alérgicos a Alternaria. Devido a esta elevada prevalência de 
sensibilização, este componente alergénico tem sido correntemente utilizado como um 
marcador de sensibilização genuína a A. alternata, sendo referido por muitos autores como 
um marcador de sensibilização à família das Pleosporaceae. Nos últimos anos, o diagnóstico 
molecular tem sido apresentado como uma ferramenta com resultados bastante promissores 
para definir o perfil de sensibilização individual de cada doente alérgico e sua associação com 
as manifestações clínicas observadas, assim como para discriminar entre casos de co-




alergénios descritos, parece não ser suficiente para justificar todo o espectro de sintomas 
clínicos observado em doentes sensibilizados a A. alternata.  
Tendo por base estes conhecimentos, estabeleceram-se como objectivos principais deste 
trabalho: por um lado, desenvolver uma tecnologia por detecção específica de A. alternata e 
espécies taxonomicamente relacionadas, utilizando Alt a 1 como um marcador molecular 
espécie-específico. E por outro lado, ampliar o painel alergénico de A. alternata, por 
caracterização de uma superóxido dismutase dependente de manganês (MnSOD) e uma 
protease de serina (SP) como dois novos alergénios de A alternata e estudar o seu papel no 
diagnóstico e prognóstico das doenças alérgicas causadas por fungos. 
As estratégias usadas para a concretização destes objectivos tiveram como princípio base o 
estudo das relações filogenéticas das espécies fúngicas que partilham proteínas homólogas 
aos alergénios de A. alternata. Assim, primeiramente, o estudo de conservação dos genes de 
expressão de Alt a 1 e homólogos possibilitou o desenho de um par de primers para o 
reconhecimento da região conservada e imunologicamente relevante, ou seja, da zona que 
codifica para os epítopos alergénicos da molécula de Alt a 1. Foram então realizados ensaios 
de PCR utilizando este par de primers e um segundo par de oligonucleótidos que permite a 
amplificação do gene completo de Alt a 1. Desta forma, foram desenvolvidas e optimizadas 
duas metodologias específicas, sensíveis e rápidas: a primeira com potencial para a detecção 
de Alt a 1 e homólogos, independentemente da fonte alergénica que o produz e uma segunda 
que permitiu detetar de forma restringida as espécies filogeneticamente próximas, A. 
alternata e A. tenuissima. 
O estudo de homologia e conservação de genes que codificam para proteínas homólogas às de 
A. alternata, foi também aplicado no desenho de primers degenerados para a região não 
variável das sequências nucleotídicas codificantes de MnSODs e SPs de origem fúngica 
disponíveis nas bases de dados. Os cDNA completos que codificam estas proteínas foram 
isolados pela realização de ensaios RACE-PCR; as respectivas moléculas recombinantes foram 
produzidas em Escherichia coli e purificadas a partir dos corpos de inclusão. A capacidade de 
reconhecimento de IgE existente em soros de uma população representativa de doentes 
sensibilizados a A. alternata foi analisada mediante immunoblotting. Desta análise 
verificaram-se prevalências de sensibilização às MnSOD e SP de A. alternata recombinantes de 
11.5% (n=61) e 10.2% (n=59), respetivamente. Estes resultados foram comunicados ao World 
Health Organization and International Union of Immunological Societies (WHO/IUIS) Allergen 
Nomenclature Sub-Committee e ambas proteínas foram registadas por esta entidade como 
alergénios clinicamente relevantes de A. alternata, oficialmente designados de Alt a 14 e Alt 
a 15. Pela realização de ensaios de inibição por ELISA pôde constatar-se que os alergénios 
recombinantes produzidos apresentavam características imunoquímicas de reatividade para a 
IgE, similares às respetivas moléculas nativas existentes num extracto crude de A. alternata. 
Adicionalmente, Alt a 14 e Alt a 15 demonstraram um alto potencial para mediar reações de 
reatividade cruzada entre A. alternata e outras espécies fúngicas de importância 





dados clínicos com as evidências de immunorreatividade e reatividade cruzada permitiu 
demonstrar que a sensibilização a Alt a 14 parece ser um indicador de desenvolvimento de 
aspergilose broncopulmonar alérgica (ABPA). Em relação a Alt a 15, a sensibilização a esta 
proteína alergénica pareceu ser restrita a doentes aparentemente sensibilizados a múltiplos 
fungos. Além disso, esta molécula parece justificar a sensibilização a A. alternata em alguns 
casos nos quais a sensibilização ao marcador de sensibilização genuína a Alternaria (Alt a 1) 
não foi verificada. Neste trabalho de investigação foi ainda apresentado um caso clínico de 
um doente com história clínica prévia de sintomas respiratórios associados a alergia 
diagnosticada a fungos ambientais, entre os quais a A. alternata, que recentemente sofreu 
um choque anafilático após a ingestão de cogumelos. Os resultados obtidos pela análise da 
reatividade da IgE sérica da doente identificaram uma MnSOD (homóloga da Alt a 14) e uma 
manitol desidrogenase (MtDH) existentes num extrato da espécie de cogumelo comestível 
Agaricus bisporus, como as moléculas responsáveis pelo desencadeamento da reação 
sistémica observada. Estas demonstrações sustentam a teoria de que uma anterior 
sensibilização a alergénios fúngicos ambientais de reatividade cruzada, tais como os que são 
apresentados neste trabalho, em particular Alt a 14, pode suscitar o desenvolvimento de 
reações sistémicas a alimentos que partilham alergénios homólogos aos sensibilizantes 
primários. 
Em suma, neste trabalho doutoral, foi desenvolvida uma técnica de PCR específica e bastante 
sensível para aplicação no controlo de contaminação por espécies fúngicas produtoras de Alt 
a 1. Além disso, dois novos alergénios de A. alternata, Alt a 14 e Alt a 15, foram 
caracterizados como alergénios minor capazes de mediar fenómenos de reatividade cruzada 
com várias espécies fúngicas, resultando em quadros clínicos de resposta alérgica complexos. 
A disponibilidade destes alergénios como moléculas recombinantes com aptidão para serem 
aplicadas em diagnóstico molecular pode constituir uma mais valia para melhorar a precisão 
do diagnóstico das doenças alérgicas provocadas por fungos, através da definição de perfis de 
sensibilização individuais. Pelas evidências clínicas demonstradas ao longo deste trabalho 
pode também concluir-se que a correta identificação de sensibilização a Alt a 14 e Alt a 15, 
pode orientar o alergologista e o doente para a tomada de medidas de prevenção de 
potenciais quadros clínicos que podem ocorrer, nomeadamente, em consequência de 
reatividade cruzada. 
Este trabalho fornece ferramentas e informações úteis e valiosas que podem contribuir para 
um avanço significativo na avaliação de exposição a alergénios de origem fúngica, assim como 
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Allergic diseases are considered to be one of the epidemics of the century, affecting 
approximately one-third of the general population. Classically, among the allergenic sources 
able to induce IgE-mediated reactions, fungi have been one of the less favored areas of study. 
It has been demonstrated that sensitization to fungal aeroallergens, particularly from 
Alternaria alternata, represents an unequivocal risk factor for the development, persistence 
and severity of asthma. Thus, the better understanding and management of fungal allergy, 
namely by improvements in the actual assessment and diagnostic approaches are needed. 
Regarding the assessment of fungal exposure, actual methodologies are generally laborious 
and time-consuming making difficult to establish or exclude a fungal contamination and 
potential associations with allergic disease. In terms of diagnosis, the main difficulty arises 
from the high number of patients that are apparently sensitized to multiple fungi in which the 
identification of primary cause of sensitization is complex. Because A. alternata is one of the 
most abundant and potent source of airborne allergens, the panel of allergenic components 
produced by this fungal specie, seems to be a very relevant target of study. Among the 
several allergens described in this mold, Alt a 1 has been demonstrated to be the most 
important, sensitizing approximately 80% of A. alternata allergic patients. For this reason, Alt 
a 1 has been used as the diagnostic marker of genuine sensitization to A. alternata. However, 
given the complex A. alternata sensitization data, which shows a significant level of poly-
sensitization, due to co-sensitization and/or cross-reactivity to several other phylogenetically 
related and non-related molds, other allergenic A. alternata components should be studied to 
explain the whole broad range of reported clinical observations. In the last years, component-
resolved diagnosis (CRD) has been shown to be a valuable tool to elucidate clinical 
observations and to differentiate between cases of co-sensitization and cross-reactivity. 
Nevertheless, the actual available panel of A. alternata allergens appears to not be enough 
for achieving an accurate diagnosis and prognosis of sensitization to this mold. 
Considering the above mentioned facts, the major aims of this work were, on one hand to 
develop an approach to specifically detect Alternaria and related species by using the A. 
alternata major allergen, Alt a 1, as a specie-specific molecular marker. And, on other hand, 
to characterize two new cross-reactive A. alternata allergens belonging to the manganese-
dependent superoxide dismutase (MnSOD) and serine protease (SP) protein families and to 
study their role in A. alternata sensitization.  
The strategies used to accomplish both aims made use of phylogenetic relationships among 
fungal species that share A. alternata allergen homologues. First, investigating conservation 
of the genes encoding for Alt a 1 and its homologues which allowed the design of a set of 
primers in the conserved immunologically relevant Alt a 1 coding sequence region. This 




was applied in a polymerase chain reaction (PCR)-based system. This approach yielded two 
rapid, sensitive and specific methodologies with high potential to be applied both for the 
detection of Alt a 1 and Alt a 1 homologues and for specific identification of the existence of 
contamination by the very close taxonomically related species A. alternata and A. 
tenuissima. The investigation of conservation of the genes encoding for A. alternata protein 
homologues, was also employed to design primers in the invariant region of fungal MnSOD and 
SP nucleotide sequences available in public databases. The aforementioned primers along 
with rapid amplification of cDNA ends (RACE) and sequencing assays allowed for the isolation 
of the full-length cDNA encoding for A. alternata MnSOD and SP. Both proteins were then 
produced as recombinant proteins in E. coli and evaluated for IgE immunoreactivity using a 
comprehensive panel of sera from patients clinically labeled as to be sensitized to A. 
alternata. Immunoblotting analysis showed that IgE antibodies from A. alternata-sensitized 
patients bound to recombinant A. alternata MnSOD and SP with prevalence of 11.5% (n=61) 
and 10.2% (n=59), respectively. These results were reported to the World Health Organization 
and International Union of Immunological Societies (WHO/IUIS) Allergen Nomenclature Sub-
Committee, and both proteins, respectively named Alt a 14 and Alt a 15, are currently 
included in the official A. alternata allergen list. By performing immunoblotting inhibition 
assays it was demonstrated that Alt a 14 and Alt a 15 are able to mediate IgE cross-reactivity 
with similar homologues allergens from other important allergenic fungal species, such as A. 
fumigatus and C. lunata, respectively. Furthermore, evidence of reactivity of Alt a 14 to IgE 
of Allergic Bronchopulmonary Aspergillosis (ABPA)-diagnosed patients was found, thus 
indicating that sensitization to this A. alternata allergen could play important implications in 
the development of ABPA. On the other hand, sensitization to Alt a 15 was shown to be 
restricted to apparently poly-sensitized patients and to justify some cases of sensitization to 
A. alternata in which there is no evidence of Alt a 1 sensitization. A homologue to Alt a 14, 
together with a manitol desidrogenase (MtDH), of the edible mushroom A. bisporus were 
identified to induce an anaphylactic shock reaction in a patient who presented a previous 
history of respiratory allergic symptoms associated to mold aeroallergens. These results were 
useful in proving that although minor allergens, A. alternata cross-reacting proteins may be 
the primary cause of strong allergic reactions to various other allergenic sources, such as 
mushrooms. 
Overall, in this work we successfully developed a specific and sensitive PCR method based on 
the amplification of regions of the gene encoding for the allergenic Alt a 1 and Alt a 1 
homologues which it is intended to be applied for environmental monitoring as well as for 
quality and biosecurity control of food stuffs. Moreover, cloning and characterization of Alt a 
14 and Alt a 15 as minor allergens of A. alternata that can trigger cross-reactive IgE response 
with other important and prevalent allergenic fungal species were also accomplished. The 
availability of these allergens as recombinant molecules suitable for application in a 
molecule-based diagnostic approach to fungal allergy can improve the diagnostic process 





prognosis of clinical manifestations and potential cross-reactivities. Furthermore, this can 
guide to a more effective specific immunotherapy using a single or a few allergenic 
molecules. Hence, this work provided valuable findings that can contribute to improving the 
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Fungal Allergens: Recent Trends 
and Future Prospects
Marta Gabriel,a Jorge Martínezb and Idoia Postigoc,*
Introduc  on
Allergic diseases affect millions of people and have shown a marked increase in recent 
years, particularly in industrialised nations (D’Amato et al. 2010). Allergens that cause 
disease include environmental allergens such as pollen, food, animal dander, and 
various fungi. Fungal spores and mycelial cells are two of the main factors causing 
several allergic diseases, including asthma, rhinitis, hypersensitivity pneumonitis, 
certain occupational lung diseases, fungal sinusitis, toxic pneumonia and allergic 
bronchopulmonary mycosis (ABPM) (Vijay et al. 2005). This broad panel of diseases 
results from the particular biology of each mould. Fungi are very common in the 
environment; therefore, the exposure to airborne spores is almost constant throughout 
the year. The inhalation and ingestion of fungal spores and vegetative cells (hyphae) 
may result in the colonization of the human body, and these particles may damage 
airways by producing toxins, proteases, enzymes (Kauffman et al. 2000) and volatile 
organic compounds (Fischer et al. 1999). Thus, moulds have a far greater impact on the 
immune systems of patients than other allergenic sources (Simon-Nobbe et al. 2008).
Although the exact prevalence of fungal allergies is not known, it is estimated that 
approximately 6 to 24% of the general population can be predicted to have allergic 
symptoms to moulds (Tariq et al. 1996; Pulimood et al. 2007). The prevalence of a 
respiratory allergy to fungi can increase to approximately 44% in atopic individuals 
Department of Immunology, Microbiology and Parasitology, Faculty of Pharmacy, University of the Basque 
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(Corey et al. 1997) and up to 80% among asthmatics (Lopez and Salvaggio 1985). 
Various studies suggest that at least 3–10% of adults and children are affected by a fungal 
allergy (Kurup et al. 2000; Bush and Protnoy 2001); however, skin reactivities ranging 
from 3–91% have been reported depending upon the population studied, fungal extracts 
used and species tested (Lehrer et al. 1986; Sprenger et al. 1988; Horner et al. 1995).
Among the allergic diseases caused by fungi, asthma has been found to be 
more prevalent, and severe reactions are commonly associated with exposure and 
sensitisation to moulds (Bush et al. 2006). Recent studies regarding asthma included 
in the Global Initiative for Asthma (GINA) yielded a global Þ gure of 197 million 
people suffering from the disease, and among these, 4.8 million adults were associated 
with allergic bronchopulmonary aspergillosis (ABPA) (Denning et al. 2013). This 
data, referring to one of several clinical manifestations in which fungi are implicated, 
indicates the relevance of this kingdom in the development of allergic diseases. We 
consider this data to be only an approximation. The exact prevalence of fungal allergy/
asthma is difÞ cult to assess because correlating fungal exposure with asthmatic 
symptoms remains problematic. One reason is that the majority of the extracts used 
in allergy testing are not standardised, which makes it difÞ cult to ascertain the true 
prevalence of fungal sensitisation (Esch 2004). Furthermore, cutaneous responses do 
not necessarily indicate the presence of disease, although these types of responses are 
helpful in deÞ ning the frequency of sensitisation and could be considered as markers 
of the severity of asthma or rhinitis (Friedlander and Bush 2005).
Fungi are ubiquitous organisms, and over 80 genera have been shown to induce 
type I allergies in susceptible persons, whereas allergenic proteins have been only 
identiÞ ed in 25 fungal genera (Simon-Nobbe et al. 2008).
The most important fungi involved in allergic diseases include the genera 
Alternaria, Aspergillus, Aureobasidium, Bipolaris, Botrytis, Candida, Curvularia, 
Cladosporium, Drechslera, Epicoccum, Fusarium, Mucor, Penicillium, Phoma, 
Saccharomyces, Stemphylium, Trichophyton and Ustilago. Among these, Alternaria, 
Cladosporium, Penicillium and Aspergillus, are classically considered the most relevant 
fungal genera that cause allergic diseases, including allergic asthma/rhinitis, ABPA 
or hypersensitivity pneumonitis.
From a traditional point of view, the diagnosis of fungal allergy has been based 
on a very well deÞ ned clinical history of the patient, on in vivo tests that include a 
skin prick test (SPT) and inhalation challenge, and on an in vitro test to detect and 
quantify the presence in serum of speciÞ c IgE or IgG antibodies directed against the 
fungal allergenic source. However, this practice involves certain unresolved issues. 
Many times, the accuracy and correlation of the results from the in vivo and in vitro 
assays are not in concordance due to the variability of the fungal extracts used. 
There is no standardisation in the production of these extracts (Esch 2004; Mari et 
al. 2003). The source of proteins could be the mycelia or the spores; therefore, the 
protein expression patterns will be different, which affects the allergenic composition. 
Moreover, the processes of growing the fungus and extracting the proteins dramatically 
affect the composition of each extract. The variability in the conditions results in a 
great variability of the content and proportion of each allergen in the extracts. All of 
the above may explain why there was no concordance between the in vivo and in vitro 
results in many cases.
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Nevertheless, these problems with fungal extracts are being overcome by the 
use of recombinant allergens. The production of these proteins in the laboratory 
offers several advantages over the production of fungal extracts. On one hand, the 
recombinant protein preparations are more homogeneous, reproducible and easier to 
standardise for use as reagents in biological and immunological tests. On the other 
hand, the recombinant allergens used for diagnostic purposes may be used as clinical 
and prognostic markers; these allergens can be used as markers of clinical severity as 
well as to differentiate among co-sensitisation, co-exposure and cross-reactivity. This 
differentiation is important because the primary sensitising moulds must be known 
for successful immunotherapy.
Aerobiology: Fungal Allergenic Sources Associated with Allergy
Allergens are biomolecules, primarily proteins that can be found in very different 
substrates and often from biological origins. These substrates and/or biological material 
constitute the allergenic sources. The most important and common allergenic sources 
are the following: mites and mite by-products; pollens and pollen by-products; fungi 
and fungal by-products; epithelia and epithelial by-products; foods and food by-
products; insects and their by-products; and drugs.
Among the above-mentioned allergenic sources, fungi are, without any doubt, 
one of the three main causes of respiratory allergy. The kingdom Fungi comprises a 
highly heterogeneous group of living organisms, including eukaryotic heterotrophic 
organisms that have either a unicellular (yeast-like) or pluricellular (a branched tubular 
structure of individual units, hyphae, that form the mycelium) vegetative structure and 
that reproduce via spores (from sexual and/or asexual origin). The most important roles 
of these organisms are the decomposition and removal of organic matter, parasitism 
(phyto- and zooparasitism), mutualism (e.g., lichens or mycorrhizae) and mycotoxin 
production.
Simon-Nobbe et al. (2008), in their excellent review, reported approximately 
eighty allergenic genera of a fungal nature. Studies of the allergic diseases caused 
by most of the species included in these genera mainly contain data concerning 
sensitisation in atopic patients, and only a limited number of genera and species 
have been studied in depth. Alternaria, Aspergillus, Cladosporium and Penicillium 
belonging to Ascomycota and Malassezia belonging to Basidiomycota are the genera 
included in this restricted group of allergenic fungi, for which not only the identiÞ cation 
as an allergenic source and the prevalence of sensitisation but also the allergenic 
composition, the role in the clinical development of symptoms and the ability to 
interact with the immune system have been reported upon exhaustively (Breitenbach 
et al. 2002; Kurup 2005).
Moulds occur in both outdoor and indoor environments, and moulds grow on 
substrates with very different natures, including non-organic surfaces. The size of 
airborne fungal spores ranges from 2–3 m (Cladosporium, Aspergillus and Penicillium) 
up to 160 m (Helminthosporium), while some species such as Alternaria longissima 
contain larger spores (500 m) (Ingold and Hudson 1993). The spore concentration in the 
atmosphere is high and ranges from 200 spores/m3 to 106 spores/m3. This concentration 
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represents between 100 to 1,000 times more than pollen concentrations (Lacey 1981; 
Burge 1989; D’Amato et al. 1995). 
The daily analysis of airborne spores shows a quantiÞ able relationship between 
each fungal taxon in the atmosphere and allows the production of an airborne 
calendar of the different allergenic sources found at each place. Each location is 
associated with a particular panel of airborne spores, depending on the climate, ß ora, 
ecological conditions, etc., and this local calendar is an important tool that helps us 
in deÞ ning the panel of allergen extracts used to evaluate allergic sensitisation. With 
this in mind and as an example, the data obtained in Barcelona, Spain, during the 
last ten years shows the presence of fungal spores belonging at least to 26 different 
genera (Agaricus, Agrocybe, Alternaria, Arthrinium; Aspergillus, Chaetomium, 
Cladosporium, Coprinus, Curvularia, Drechslera, Epicoccum, Fusarium, Ganoderma, 
Helminthosporium, Leptosphaeria, Nigrospora, Penicillium, Pithomyces, Pleospora, 
Polytricium, Puccinia, Stemphylium, Tilletia, Torula, Ustilago, Venturiaceae and 
Xylariaceae). However, only a few genera have maximums of more than 100 spores/
m3 (Agaricus: 350 spores/m3; Alternaria: 180 spores/m3; Aspergillus/Penicillium: 450 
spores/m3; Cladosporium: 4,500 spores/m3; Coprinus: 500 spores/m3; and Ustilago: 
750 spores/m3). The periodic measurements reveal a high variability among the spore 
concentrations of each genera, and thus the genus Alternaria had a maximum airborne 
spore concentration of 180 spores/m3 during the period 1994–2013, but the mean value 
in the same period was 60 spores/m3 (http://www.lap.uab.cat/aerobiologia/es/). This 
data can be extended to other studies with similar objectives, which show the data 
associated with each location.
The composition of fungi growing inside homes depends on the outdoor fungal 
panel and the species that grow indoors, and the latter are inß uenced by humidity, 
ventilation, the content of biologically degradable material, and the presence of 
pets, plants and carpets (Dharmage et al. 1999). Alternaria spores are found in the 
atmosphere of many different locations as one of the predominant spore types (Newson 
et al. 2000; Sanchez and Bush 2001; Rizzi-Longo et al. 2009), and several studies 
performed worldwide indicate that sensitivity to moulds is a primary risk for asthma 
and that Alternaria alternata is the mould species responsible for the highest percentage 
of mould sensitivities (Gergen and Turkeltaub 1992; Peat et al. 1993; Halonen et al. 
1997; Das and Gupta-Bhattacharya 2012), even though most individuals sensitised 
to moulds respond to several mould species (Postigo et al. 2011).
Although the number of spores in the environment is high, much more than the 
pollen grains, the occurrence of fungal sensitisation through the airborne counts is 
low, and the correlation between the number of spores and mould allergy is weak. 
Therefore, why would the fungi produce lower rates of sensitisation than pollens? Most 
likely, the availability of the fungal allergens released by the spores is signiÞ cantly 
lower than that of the allergens released by the pollen grains. Alternatively, only a 
few main allergens have been described from fungi compared with pollens. Among 
these, Alt a 1 is the main marker of fungal sensitisation and the main risk factor for 
asthma among the fungal allergens (Lizaso et al. 2008; Postigo et al. 2011; Feo-Brito 
et al. 2012). Despite the fungal major allergens with no cross-reactivity as Alt a 1 or 
Asp f 1 are considered the main causes of fungal sensitization other fungal allergens 
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eliciting lower sensitization prevalence and limited cross-reactivity, also can play and 
important role not only in sensitization but  also in the development of the allergy.
The prolonged intense exposure to fungal sources mimics the exposure to other 
perennial allergens, which likely contributes to both the chronicity and severity 
of asthma in mould- and especially Alternaria-sensitive subjects. The clinical 
development of an allergy from the components of a mycotic nature could be better 
understood by taking into account other minor allergens such as proteases that are 
common to a great variety of fungal species and that also induce inß ammation and 
may thereby act as adjuvants in allergic sensitisation (Snelgrove et al. 2014).
Fungal Allergens
The World Allergy Organisation deÞ nes allergens as “antigens that trigger an allergy”. 
Most of these allergens that bind IgE antibodies are proteins that are often linked to 
carbohydrates and are derived from a biological source. In recent decades, a large 
number of these allergens have been studied from a molecular point of view; the 
structural and functional characteristics of these allergens have been examined to 
answer the question “what makes an allergen an allergen?” (Stadler and Stadler 2003; 
Breiteneder and Radauer 2004; Ferreira et al. 2004; Jenkins et al. 2005; Radauer and 
Breiteneder 2006; Jenkins et al. 2007). Radauer et al. (2008) conÞ rmed that allergens 
are distributed among two hundred protein families and that 16% of these families 
include 50% of the known allergens (Fig. 1). This data suggests that the narrow 
spectrum of biological functions of the allergens might explain the allergenic proÞ le 
of these proteins.
There are more than 70,000 fungal species recorded in the literature, but only one 
hundred genera have been described as allergenic sources (Simon-Nobbe et al. 2008). 
Figure 1. Number of Allergens Belonging to Each Family Protein.
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Simon-Nobbe et al. (2008) listed approximately two hundred fungal allergens belonging 
to 24 fungal genera, and the Nomenclature Subcommittee of the International Union of 
Immunological Societies (IUIS; www.allergen.org) describes 108 allergens, of which 
85 belong to the Ascomycota phylum and 23 belong to the Basidiomycota phylum.
Among the Ascomycota associated with allergic disorders, Alternaria alternata is 
one of the most frequently described species (D’Amato et al. 1997; Zureik et al. 2002; 
Mari et al. 2003). The major allergen of this species, Alt a 1, is recognised by up to 
98% of A. alternata-sensitised patients (Asturias et al. 2005), and sensitivity to this 
allergen was shown to be a risk factor for life-threatening asthma (Lizaso et al. 2008; 
Postigo et al. 2011; Feo-Brito et al. 2012). The function of Alt a 1 has been recently 
studied, and this protein seems to act as a competitive inhibitor of the thaumatin-like 
proteins (Gómez-Casado et al. 2014). Taking into account that several members of the 
thaumatin protein family display signiÞ cant in vitro inhibition of hyphal growth and 
sporulation by various fungi, the Alt a 1 could be a relevant fungal protein involved in 
the Þ topathogenicity of Alternaria members (Gómez-Casado et al. 2014). Previously, 
the molecular structure of Alt a 1 was described (Chruszcz et al. 2012), and it was 
demonstrated that Alt a 1 conforms to a new type of protein family found exclusively in 
fungi. Sáenz-de-Santamaría et al. (2006) and Martínez et al. (2006) demonstrated that 
Alt a 1 is expressed by both Alternaria and other members of the Pleosporaceae family, 
including the allergenic species Stemphylium botryosum and Ulocladium botrytis. 
Their results showed that Alt a 1 must be considered a species- and family-speciÞ c 
allergen, and Alt a 1 must be used as the main marker for evaluating sensitisation to 
fungal allergenic species belonging to the Pleosporaceae family.
In addition to Alt a 1, the enolase Alt a 6 from the allergen array described for 
Alternaria also has a high diagnostic value. Several authors demonstrated that this 
allergen can play an important role in the phenomenon of cross-reactivity among 
several fungi and among species that belong to different phyla (Simon-Nobbe et al. 
2000; Wagner et al. 2000). However, this protein can be considered to be a minor 
allergen because Alt a 6 is only able to sensitise approximately 15–22% of patients 
who are allergic to moulds (Simon-Nobbe et al. 2000; Wagner et al. 2000). Moreover, 
a high proportion of mould-allergic patients seem to be poly-sensitised to several 
mould species (Horst et al. 1990).
Postigo et al. (2011) evaluated the diagnostic value of Alt a 1 and enolase using 
the resolved-component diagnosis of allergy in a group of 30 patients who had been 
deÞ ned by a cutaneous and in vitro test as only allergic to Alternaria. The results 
revealed that the 23% of the analysed patients were indeed multi-sensitised and that 
enolase played an important role in the cross-reactivity phenomenon. However, the 
authors concluded that the panel of allergens used in the study was not sufÞ cient 
for the accurate diagnosis of a fungal allergy. Among the allergens described for 
Alternaria (Table 1), at least nine have been identiÞ ed in closely related moulds such as 
Cladosporium herbarum. Other Alternaria allergens, including heat shock protein 70, 
enolase, aldehyde dehydrogenase and glutathione-S-transferase, have been described 
in both fungal and non-fungal species (Simon-Nobbe et al. 2008). Recently, a new 
cross-reactive allergen from Alternaria has been included in the IUIS allergen list. The 
new allergen is a manganese-dependent superoxide dismutase (MnSOD) that is highly 
homologous to the MnSOD of Aspergillus fumagitus, Asp f 6, an allergen considered 
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to be a marker of ABPA (Postigo et al. 2011). The clinical relevance of this allergen 
must be studied, but this MnSOD could have important implications in Alternaria 
sensitisation as a risk factor for the development of ABPA (Jubin et al. 2010).
Aspergillus is an allergenic mould belonging to Ascomycota. This mould is 
frequently found growing in decaying vegetation or indoors (Kurup et al. 2000; Terr 
2004) releasing large quantities of spores, which can reach the terminal airways via 
inhalation (Kurup and Banerjee 2000; Vijay and Kurup 2004). In some cases, large 
clusters of spores are deposited in the upper respiratory tract (Kurup 2003), causing 
disorders ranging from allergic rhinitis, sinusitis or asthma to hypersensitivity 
pneumonitis and ABPA (Terr 2004).
The IUIS lists 31 allergens belonging to Þ ve species of Aspergillus, including 
A. ß avus, A. versicolor, A. niger, A. oryzae and A. fumigatus. Among these species, 
A. fumigatus is implicated in approximately 80% of Aspergillus-related infections 
(Simon-Nobbe et al. 2008). Due to its high prevalence, a large number of allergens from 
A. fumigatus have been cloned, characterised and puriÞ ed as recombinant allergens 
(Crameri and Blaser 1996; Crameri et al. 2006). 
The main major allergens of A. fumigatus are Asp f 1 and Asp f 3 (Table 1). The 
Þ rst, Asp f 1, is a non-glycosylated ribotoxin of 18 kDa that is recognised by 85% 
of the ABPA patients as well as asthmatic patients with a positive cutaneous test to 
this mould (Arruda et al. 1990). Arruda et al. (1992) demonstrated that Asp f 1 was 
abundantly released after germination of the spores and during the early phases of 
fungal growth; therefore, Asp f 1 was considered to be a virulence factor promoting 
the colonisation and infection of human tissue. Kurup et al. (1998) analysed the 
B- and T-cell epitopes of this allergen and demonstrated that the C-terminal region 
(aa 115–149) was involved in both humoral and cell-mediated immune responses in 
ABPA, whereas the T-cell epitopes were localised in aa 45–65 and aa 106–125. This 
allergen is unique and has not been found to share sequence homology with any other 
known allergen (Bowyer and Denning 2007).
The second main allergen, Asp f 3, is a 19 kDa protein that binds IgE in 72% 
of the ELISA-determined cases, and it is known that this allergen shares common 
IgE-binding epitopes with peroxisomal membrane proteins from Candida boidini 
(Hemmann et al. 1997). The clinical relevance of Asp f 3 in Aspergillus disorders 
was demonstrated long ago (Hemmann et al. 1998). The analysis of the B- and T-cell 
epitopes by Ramachandran et al. (2002) demonstrated the presence of 12 amino acids 
located at the N-terminus and 8 at the C-terminus that are critical for IgE binding.
Other allergens from Aspergillus have been described, including Asp f 2, Asp f 4 
and Asp f 6 (Kurup and Banerjee 2000; Vijay and Kurup 2004), and are available as 
recombinant proteins (Crameri and Blaser 1996). Asp f 4 and Asp f 6 are intracellular 
proteins; thus, the availability of these proteins as aeroallergens is unlikely. It seems 
that the process of sensitisation to these allergens occurs when the mould is growing 
inside the lungs; therefore, some authors have concluded that the use of these two 
markers is sufÞ cient to allow a precise diagnosis of ABPA (Hemmann et al. 1999). 
As can be observed in the annexed tables, a large number of fungal allergens have 
been described and this number is expected to increase in the coming years. Currently, 
special attention is being given to several allergens that have protease activity. The 
biological function of these allergens seems to be closely related to the initiation of the 
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sensitisation process and the pathogenicity of fungal aeroallergens. These proteases 
act directly on the pulmonary epithelium and disrupt the cells, thereby eliciting robust 
and rapid inß ammation, which allows the massive inß ux of other allergens and induces 
the exacerbation of asthma (Snelgrove et al. 2014). These proteases are founded in 
several fungal genera and it is thought that they are important cross-reactivity allergens.
Diagnosis of Fungal Allergy 
Fungi are an important source of airborne allergens associated with asthma and allergic 
rhinitis. The speciÞ c diagnosis of fungal allergy is made by combining aerobiological 
studies, a clinical history, complementary tests (mainly the determination of speciÞ c 
and total IgE) and a careful analysis of the symptoms in relation to the causative 
agents, the allergens.
However, to date, the diagnosis of an allergy to fungi has been difÞ cult in many 
cases and inefÞ cient due to various reasons, such as the high variety of fungal species, 
the difÞ culty in species identiÞ cation, the complexity and variability of the allergen 
extracts of fungal origin and the lack of quality and standardisation of the most available 
fungal extracts (Martínez et al. 1994).
Among the patients allergic to moulds, there are commonly a large proportion of 
individuals sensitised to several fungal species (Zureik et al. 2002; Simon-Nobbe et 
al. 2008; Postigo et al. 2011). This situation complicates the Þ nal diagnosis of these 
patients. The diagnosis of these cases by implementing individualised allergens has 
gained increased attention.
The application of genomics and proteomics to the study of allergenic proteins 
has allowed the development of new diagnostic tools that make the diagnosis of 
the allergy more effective. The new models are based on the identiÞ cation of the 
individual molecules that are involved at the beginning and during the development 
of the allergenic phenomenon.
At the beginning of the 21st century, Valenta et al. (1999) described the basis 
of the molecular diagnosis of allergy, which involves using a classical technique to 
measure the speciÞ c IgE levels (ImmunoCAP ®), wherein the complete allergen 
extracts (allergen sources) coupled to the solid phases are replaced with individualised 
allergens, either in their native form or as recombinant proteins.
A few years later, the microarray technique was applied to the CRD concept. 
Small slides spotted with very small quantities of allergens allowed the molecular 
diagnosis of allergy against hundreds of allergens using a minimal quantity of serum 
(Jahn-Schmid et al. 2003). This new concept (CDR) has allowed the individualised 
proÞ les of sensitisation in the allergic patient to be precisely deÞ ned and subsequently 
associated with the clinical expression of the allergy.
Similarly, concepts such as cross-reactivity, multiple or primary sensitisation, the 
prediction of the severity of the allergic reactions and the association of the molecular 
proÞ les of sensitisation with the development of clinical symptoms are now easier to 
understand and evaluate, whereas these parameters were previously difÞ cult to assess 
(Valenta and Dietrich 2002; Casquete et al. 2009; Knol and Knulst 2010).
Currently, there are no doubts regarding the diagnostic effectiveness of replacing 
allergenic sources with individual allergens. By applying a molecular diagnosis, 
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we can overcome several problems with the standardisation of allergenic extracts, 
including the variability of the fungal strains, the variability in the batch-to-batch 
production, the choice of the fungal structure to use as raw material, the type of culture 
and technology used to prepare the allergen extracts and the autodegradation of the 
extract once obtained.
A large number of fungal allergens have been identiÞ ed (Table 1). However, the 
lack of availability of large quantities of these allergens for widespread use limits 
their diagnostic application. 
The use of CRD and, more speciÞ cally, the miniaturised version of CRD, which 
can simultaneously evaluate a patient’s sensitisation against hundreds of allergens 
belonging to different Phyla, allow us to associate the molecular sensitisation proÞ les 
with different stages of the allergic phenomenon and to Þ nd molecular markers that 
predict the severity of the allergic reactions, molecular markers of cross-reactivity and 
molecules able to differentiate between sensitisation and allergy (Kurup et al. 2005; 
Ebo et al. 2010a; Ebo et al. 2010b; Nicolaou et al. 2010).
Out of more than 70,000 fungal species described in the literature, Simon-
Nobbe et al. (2008) only refer to somewhat less than a hundred genera that have been 
described as allergenic sources. The same authors report regarding the identiÞ cation 
of somewhat more than 200 individualised allergens that belong to 24 genera of fungi 
(Simon-Nobbe et al. 2008).
In view of this data, we may ask ourselves whether all sources of fungal allergens 
are equally relevant in the diagnosis of a fungal allergy. Are these 200 fungal allergens 
enough for the efÞ cient diagnosis of a fungal allergy?
Studies on aerobiology, the cutaneous reaction to fungal allergens and allergenic 
characterisation, suggest that the minimum number of species that will ensure an 
acceptable diagnosis of an allergy to fungi would include the following: A. alternata, 
Aspergillus fumigatus, Cladosporium herbarum, Epicoccum nigrum, Fusarium roseum, 
Penicillium crisogenum, Candida spp. and Malassezia spp. (Crameri et al. 2006). 
Recently Postigo et al. (2011) has stated that Curvularia lunata should be another 
species to be included in the panel of essential fungi used for diagnosis. Additionally, 
if we consider the results of studies conducted in different geographical areas, we 
should also include Trichophyton spp. (Mari et al. 2003), Helminthosporium spp., 
Trichoderma spp. and Aureobasidium spp. (Zureik et al. 2002). According to this 
data, if we look for more relevant species described in the literature or in new studies 
developed in other geographical areas, it would be very likely that we would have to 
add new fungal allergenic sources to the above-mentioned panel.
However, taking into account the ratio between the individualised allergens and 
their allergenic sources, we can assert that the 200 described fungal allergens belong to 
approximately 20 genera (Simon-Nobbe et al. 2008), and that most of these allergens 
are related to each other because the allergens belong to the same protein family. 
Therefore, these allergens could form an allergic unit which would belong to the same 
group. Thus, from the allergens referred to by Simon-Nobbe et al. (2008), the number 
of allergens homologous to Alt a 1 described in other species but phylogenetically 
related to A. alternata is approximately Þ fty.
Alt a 1 is most likely the best allergen to deÞ ne the diagnosis of a respiratory 
allergy caused by moulds in our environment (Postigo et al. 2011; Portnoy et al. 2008; 
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Bartra et al. 2009) and is a very useful tool as a marker of asthma severity (Feo-Brito 
et al. 2012). An allergen such as fungal enolase is a panallergen and is associated with 
cross-reactivity. This allergen could explain part of the apparent multiple sensitisations 
commonly observed in this type of clinic (Postigo et al. 2011). In the same way, 
it can be observed in Table 1 that there are more allergens belonging to unrelated 
species, including serine proteases, peroxisomal proteins and the ribosomal proteins 
P1 and P2, which could be considered to be markers of cross-reactivity between non-
phylogenetically related species. These proteins may be responsible for the apparent 
multi-sensitisations that are frequently observed in fungal allergies (Simon-Nobbe et 
al. 2008; Horst et al. 1990).
C onclusions
For a long time, the diagnosis of fungal allergy has been difÞ cult due to the complexity 
of molds and the variability in the allergenic composition of the fungal extracts used. 
However, nowadays, using biological tools including the genomic and proteomic, 
we are able to identify new individual allergens belonging to different fungal sources 
that have been associated with a different diagnostic value in the diagnosis of fungal 
allergy. Some allergens have been identiÞ ed as markers of the risk to suffer asthma 
such as Alt a 1 and the others are implicated in cross-reactivity and/or poly- and co-
sensitivity reactions such as the enolase. Currently, it remains necessary to identify 
which proteins are implicated in the cross-reactivity phenomenon. Using the above-
mentioned tools, the genomic and proteomic, we are able to obtain these allergens as 
individualised molecules. The availability of these allergens would make it possible 
to study the role of each molecule in the diagnosis and prognosis of a mould allergy, 
thereby providing a solution for poly-sensitisation and/or cross-reactivity.
The future of the molecular diagnosis of a fungal allergy is moving in two main 
directions: (1) the identiÞ cation of new fungal allergens, their structure and bioloogical 
activities, including markers of both primary sensitisation and cross-reactivity; and 
(2) the establishment of the relationship between each allergen and the expression of 
the different clinical proÞ les that occurs in mold allergy.
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Alternata alternata spores are considered a well-known biological contaminant and a very 
common potent aeroallergen source that is found in environmental samples. The most intense 
exposure to A. alternata allergens is likely to occur outdoors; however, Alternaria and other 
allergenic fungi can colonize in indoor environments and thereby increase the fungal 
aeroallergen exposure levels. A consequence of human exposure to fungal aeroallergens, 
sensitivity to A. alternata, has been unequivocally associated with increased asthma severity. 
Among allergenic proteins described in this fungal specie, the major allergen, Alt a 1, has 
been reported as the main elicitor of airborne allergies in patients affected by a mold allergy 
and considered a marker of primary sensitization to A. alternata. Moreover, A. alternata 
sensitization seems to be a triggering factor in the development of poly-sensitization, most 
likely because of the capability of A. alternata to produce, in addition to Alt a 1, a broad and 
complex array of cross-reactive allergens that present homologues in several other allergenic 
sources. The study and understanding of A. alternata allergen information may be the key to 
explaining why sensitization to A. alternata is a risk factor for asthma and also why the 
severity of asthma is associated to this mold but not to other aeroallergens that are 
commonly found in the environment. Indeed, compared to other common environmental 
allergenic sources, such as pollens and dust mites, fungi are reported to be neglected and 
underestimated. The rise of the A. alternata allergy has enabled more research into the role 
of this fungal specie and its allergenic components. Indeed, recent research on the 
identification and characterization of A. alternata allergens has allowed for the consideration 
of new perspectives in the categorization of allergenic molds, assessment of exposure and 
diagnosis of fungi-induced allergies. 
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Alternaria alternata is one of the most common saprophytes found worldwide and has been 
clinically associated to asthma (Bush and Prochnau, 2004), allergic rhinosinusitis (Schell, 
2000), hypersensitivity pneumonitis (Ogawa et al., 1997), occulomycosis (Ozbek et al., 2006), 
onychomycosis (Romano et al., 2001), skin infections (Mayser et al., 2002) and Allergic 
Bronchopulmonary Mycosis (ABPM) (Singh and Denning, 2012; Chowdhary et al., 2012). 
Although there is a wide range of clinical manifestations, A. alternata is rarely found to be a 
cause of invasive infections in humans. This fungal specie is mainly related to the induction of 
IgE-mediated respiratory diseases. A. alternata spores are considered one of the most 
abundant and potent sources of airborne sensitizer allergens. The most intense exposure to A. 
alternata allergens is likely to occur outdoors; however, Alternaria and other allergenic fungi 
can colonize in indoor environments and thereby increase exposure levels (Salo et al., 2005). 
The true prevalence of sensitization to A. alternata has been difficult to estimate, and 
several epidemiological and diagnostic studies have reported a highly variable prevalence of 
human IgE reactivity to Alternaria. The European Community Respiratory Health Survey found 
that 4.4% of an adult population (n=11355) was sensitized to Alternaria (Bousquet et al., 
2007). More recently, in a large skin test study funded by the Global Asthma and Allergy 
European Network (GA(2)LEN) that involved 17 collaborating centers from 14 European 
countries, Alternaria sensitization prevalence was approximately 9%, with sensitization rates 
ranging from 2% (Finland) to 23.8% (Greece) (Burbach et al., 2009). Among a fungal-sensitized 
population, more than 60% reacted to diagnostic A. alternata extracts (Mari et al., 2003). 
There are some population groups in which the A. alternata sensitization rates are much 
higher. Mold sensitivity, particularly to A. alternata, seems to be much more prevalent in the 
asthmatic population (Neukirch et al., 1999). Younger respiratory allergic patients seem to be 
more at risk for A. alternata sensitization than older ones (Mari et al., 2003; Katotomichelakis 
et al., 2012). Farm and sawmill workers have also been reported to be at high risk for 
occupational airway disease caused by A. alternata because significant levels of A. alternata 
allergen have been monitored in farms (Prester and Macan, 2010). 
It is well known that most individuals sensitized to A. alternata present associated allergic 
manifestations that require medical attention. In particular, in the GA(2)LEN study, clinically 
relevant symptoms were clearly noticed in 69% of the European patients who were sensitized 
to Alternaria (Burbach et al., 2009). The severity of typical allergic reactions varies from mild 
to potentially life-threatening, and it is dependent on several internal and external factors. 
The most severe IgE-mediated response to A. alternata aeroallergens is severe asthma that is 
characterized by impaired lung function and frequent exacerbations that may result in 




associated with increased asthma severity, hospital admissions to intensive care for asthma 
and deaths related to asthma (Neukirch et al., 1999; Black et al, 2000; Zureik et al., 2002). 
Because A. alternata has been increasingly recognized as a powerful respiratory allergic 
disease inducer, it has been proposed that at least some A. alternata allergens might play a 
role in the underlying mechanisms of allergic reaction severity. This may be the key to finding 
an explanation for why sensitization to A. alternata is a risk factor for asthma and why 
asthma severity is associated with this mold but not with other aeroallergens that are 
commonly found in the environment as pollens (Zureik et al., 2002). Similarly, allergenic 
protein components of this mold may be a clue for understanding the interesting recent 
finding that Alternaria activates the innate immune system and enhances lung inflammation 
induced by unrelated allergens such as grass pollen (Kim et al., 2014). However, compared 
with other common allergenic sources, fungi, particularly, A. alternata, are still neglected 
and underestimated source of allergens (Crameri et al., 2014).  
Considering the above-mentioned facts, there is a clear need to identify the complete array 
of allergenic components from A. alternata and elucidate the role of these proteins in the 
development of respiratory allergies from biology, diagnosis, prognosis and disease 
management perspectives. At present, a total of 12 allergenic proteins, fulfilling the World 
Health Organization and International Union of Immunological Societies (WHO/IUIS) Allergen 
Nomenclature Sub-committee criteria, have been officially listed as A. alternata allergens. 
Another five A. alternata allergenic proteins are encompassed in other allergen platforms. 
These lists include proteins that are restricted to a small number of fungal species that are 
taxonomically related to A. alternata and ubiquitous proteins that are conserved throughout 
the evolutionary process; these proteins present their homologs in several fungal families. 
The existence of multiple homologue allergens across the fungal kingdom that carry cross-
reactive epitopes that are structurally indistinguishable from IgE-binding epitopes may raise a 
considerable problem in the diagnosis and classification of fungal allergies (Bowyer et al., 
2006). In agreement with this finding, compelling evidence shows that apparent sensitization 
to multiple fungi represents a frequent clinical observation in patients sensitized to A. 
alternata and may be a consequence of the existence of IgE cross-reactivity between fungal 
proteins (Gupta et al., 2002; Crameri et al., 2009). 
Recent phylogenetic studies have increasingly clarified that clinical IgE reactivity data reflect 
the taxonomical distribution of the fungal allergenic sources in a majority of the cases 
(Soeria-Atmadja et al., 2010). Thus, individualized fungal allergens should be fully 
characterized and analyzed with respect to protein family membership, taxonomic 
distribution and interspecies variability. In this way, establishing relationships between A. 
alternata allergens and the homologues expressed by other allergologically important fungal 
species might provide valuable information for defining a taxonomic categorization of fungal 





allergens as molecular markers will contribute to an understanding of their potential role in 
fungal biology, improve diagnostic decisions by prediction of cross-reactivity and develop 
more robust detection tools to assess exposure allergen levels. Correctly assessing the 
exposure to aeroallergens in the environment is of major importance for predicting the risk of 
respiratory symptoms in an atopic population and informing the implementation of 
appropriate public health measures. The use of specific allergens as tools to accurately 
detect allergen contaminants and thereby enable the identification of the fungal origin 
source seems to be a promising strategy. 
This review is intended to focus on relevant issues regarding A. alternata sensitization and its 
allergens, such as the immunological characterization and clinical relevance of the allergens 
identified to date, the phylogenetic relationships based on shared allergen homologues and 
advances in the assessment of A. alternata exposure and diagnosis of fungal sensitization.  
 
2. Alternaria alternata allergens and their sensitization prevalence 
Significant research has been conducted to identify and characterize the proteins that are 
involved in A. alternata allergy. Alternaria allergens are a diverse group of molecules that 
possess different chemical and biological properties. To date, 12 A. alternata allergens are 
included and officially recognized by the WHO-IUIS Allergen Nomenclature Sub-committee 
(Table 1).  
Thus, the A. alternata allergens recognized to date, as well as their clinical relevance 
concerning an A. alternata allergy, are discussed extensively here. 
 
2.1. Alt a 1 
Alt a 1 is predominantly located in the cell wall of airborne Alternaria spores (Twaroch et al., 
2012) that access the respiratory tract and elicit allergic reactions in patients affected by a 
mold allergy. It is considered to be the marker of primary sensitization to A. alternata and is 
undoubtedly the more extensively characterized A. alternata allergen. The population that is 
allergic to A. alternata presents approximately 80% of the sensitization prevalence for Alt a 
1. This allergen is an abundant protein expressed by the Alternaria species, which is most 
likely why this allergen displays very high values of sensitization incidence. 
Natural Alt a 1 is a 30 kDa dimer that dissociates into 16.4 and 15.3 subunits under reducing 
conditions, thus suggesting a disulfide bond linking the monomers (Deards and Montague, 
1991). Investigations by means of molecular dynamics suggested that Alt a 1 possesses a 
greatly stable dimeric structure presenting epitopes with a proper orientation for IgE cross-




al., 2014). Two linear epitopes (K41-P50 and Y54-K63) showing consistent reactivity with 
serum IgE from an Alternaria allergic patient were identified in the Alt a 1 protein sequence 
(Kurup et al., 2003). Recently, the recombinant form of Alt a 1 has been used to analyze the 
three-dimensional structure of the molecule by X-ray crystallography (Chruszcz et al., 2012). 
In this work, the Alt a 1 protein presented a dimeric β-barrel structure, a completely novel 
fold among allergens that potentially define a new fungal protein family with an unknown 
function (Chruszcz et al., 2012). Although the function of this major allergen remains unclear, 
evidence has raised some hypotheses for the role played by this protein in fungal biology:  
a) Alt a 1 release was detected to be significantly higher in germinated Alternaria 
spores, which indicates that this allergen might be involved in spore germination 
(Mitakakis et al., 2001). 
b) Its A. brassicicola homologue was found to be highly expressed during the 
infection process of A. thaliana (Cramer and Lawrence, 2004).  
c) Alt a 1 was found to induce the expression of plant defense proteins belonging to 
the PR5-TLP family and interact with it as a competitive inhibitor (Gómez-Casado 
et al., 2014).  
The last two findings suggest that the role of Alt a 1 can be related to virulence and fungal 
infection pathogenicity. 
Alt a 1 is a conserved protein that is highly specific for Alternaria and its related taxa 
because homologs of Alt a 1 have been reported in other Pleosporaceae species (Hong et al., 
2005). A numerous list of Alt a 1 and Alt a 1-like genes and proteins has been deposited into 
databases. 
 
2.2. Alt a 3 and Alt a 5 
The first report of Alt a 3 and Alt a 5 as minor A. alternata allergens occurred when De Vouge 
et al. (De Vouge et al., 1998) cloned two sequences encoding IgE-binding fragments of A. 
alternata allergens by screening the A. alternata cDNA library with A. alternata-sensitive 
patients’ pooled sera. The IgE-binding fragment that presented high homology in comparison 
with a region near the C-terminus of a heat shock protein 70 kDa from Cladosporium 
herbarum was recognized on immunoblotting by 5% of the sera from A. alternata-sensitized 
patients, and it was officially named Alt a 3. Members of the HSP 70 protein family are highly 
conserved across both prokaryotic and eukaryotic organisms and play a major role protecting 
the cell during thermal and oxidative stress (Kiang and Tsokos, 1998). 
The second A. alternata allergenic fragment cloned by De Vouge et al. (Alt a 5) was identified 
as belonging to the acidic ribosomal protein P2 family, and the recombinant protein had 





et al., 1998). Biologically, these proteins are known to be ribosomal components that are 
involved in interactions with elongation factors during the course of protein synthesis 
(Tchórzewski, 2002). 
 
2.3. Alt a 4, Alt a 7 and Alt a 10  
Achatz and collaborators identified, cloned and characterized Alt a 4, Alt a 7 and Alt a 10 
allergens (Achatz et al., 1995; Achatz et al., 1996).  
Alt a 4 is a 57 kDa A. alternata (Alt a 4) that bound IgE from 42% of the A. alternata 
sensitized population. In turn, the 22 kDa Alternaria protein was homologous to YCP4 yeast 
(Alt a 7) and Alt a 10, an 11 kDa aldehyde dehydrogenase bound IgE in 7% and 2%, 
respectively, of the Alternaria-sensitive subjects (Achatz et al., 1995; Achatz et al., 1996). 
 
2.4. Alt a 6 
cDNA coding for A. alternata enolase was cloned by two research groups using a similar 
approach that consisted of screening the cDNA library using a C. herbarum DNA fragment as a 
probe (Unger et al., 1999, Simon-Nobbe et al., 2000). In one of the studies, a skin test with 
recombinant protein showed a positive response in two of the seven allergics to Alternaria 
(Unger et al., 1999). In the second study, blotted purified recombinant Alt a 6, was 
recognized by 22% of A. alternata sensitized patients’ sera (n=23) (Simon-Nobbe et al., 2000). 
Recently, a similar Alt a 6 sensitization prevalence among an A. alternata allergic population 
(n=30) was found by the application of resolved-component diagnosis (Postigo et al., 2011). 
Native enolase purified from an A. alternata extract possesses high thermostability and 
presents a molecular weight of 47 kDa and an optimal pH of 6,8 (Kustrzeba-Wójcicka and 
Kmiecik, 2001). Enolases (also called 2-phospho-D-glycerate hydrolyases or phosphopyruvate 
hydratase) are highly expressed key enzymes of glycolysis and gluconeogenesis catalyzing the 
interconversion of 2-phospho-D-glycerate and phosphoenolpyruvate (Wagner et al., 2000). 
Because these enzymes are highly conserved, investigations of IgE reactivities of various 
fungal enolases by cross-inhibition experiments revealed that enolase is a highly cross-
reactive fungal allergen (Simon-Nobbe et al., 2000), as described in detail below. 
 
2.5. Alt a 8 
The recombinant A. alternata NADP*-dependent mannitol dehydrogenase (MtDH), 28.6 kDa 




MtDH of C. herbarum was confirmed by inhibition-ELISA experiments (Schneider et al., 2006). 
These enzymes mediate the reversible conversion of mannitol to fructose in the metabolism 
cycle of mannitol, which serves as a storage or translocated carbohydrate that seems to be 
needed for fungal phytopathogenesis (Vélëz et al., 2007; Vélëz et al., 2008). 
 
2.6. Alt a 13 
Alt a 13 is a 26KDa protein that belongs to the glutathione-S-transferase (GST) protein family. 
The biochemical function of these enzymes is that they take part in the detoxification of 
endogenous and xenobiotic compounds or their metabolites by catalyzing their 
biotransformation in glutathione conjugates that present lower toxicity and are more easily 
excreted outside the cell than their parental compounds (McGoldrick et al., 2005).  
Shankar et al. produced the recombinant protein and referred to Alt a 13 as a major A. 
alternata allergen demonstrating that 14 of the 17 patients who presented a skin reaction to 
an A. alternata extract recognized rGST and nGST (Shankar et al., 2006). In a recent report, 
the same authors bioinformatically identified epitopes and residues of the Alt a 13 molecule 
that seemed to be involved in the IgE-reactivity (Shankar et al., 2009).  
 
2.7. Alt a 14 
Manganese-dependent superoxide dismutases (MnSODs) are phylogenetically conserved 
enzymes that are involved in defense against oxidative stress by preventing oxidative damage 
(Crameri et al., 1996). Our research group identified the natural A. alternata MnSOD, Alt a 
14, as an IgE-reactive protein of 24 kDa (Postigo et al., 2011). More recently, the recombinant 
molecule was produced, and it was demonstrated that 11.5% of the sixty-one A. alternata-
sensitized patients’ sera reacted to the rAlt a 14 by IgE immunoblotting (Gabriel et al., 
2015c). In the same work, we found that rAlt a 14 was also able to bind IgE from patients who 
were clinically diagnosed as suffering of Allergic Bronchopulmonary Aspergillosis (ABPA), 
which suggested that the sensitivity to this A. alternata allergen may be related to the 
pathogenesis of ABPM. 
 
2.8. Alta 15 
Serine proteases (SPs), particularly subtilisin SP, are recognized as one of the most important 
families of allergenic proteins (Radauer et al., 2008), and they have been extensively 
designed as pan-allergens (Lee et al., 2007; Shen et al., 2007). Recently, a subtilisin-like 
serine protease was cloned and characterized as an official allergen of A. alternata, named 





population sensitized to A. alternata (n=59) bound to rAlt a 15 with a prevalence of 10.2%. It 
was also showed that IgE-mediated sensitization to this allergen is highly specific for patients 
who are poly-sensitized to molds, namely to C. lunata (Gabriel et al., 2015a). 
It is well known that the proteases produced by various allergenic sources may directly 
impact respiratory epithelial biology, thus playing an important role in initiating an allergic 
response in the lung (Yike, 2011; Wills-Karp et al., 2010). Proteases, which act at the same 
time as allergen, may enhance bystander-type reactions, thereby facilitating antigen access 
to the subepithelium and potentially modifying other allergens in such a way that they 
become more potent antigens. 
Furthermore, it has been demonstrated that intrinsic SP-specific activity of Alternaria 
alternata extracts plays an important role in the physiopathogenesis of asthma via the 
elicitation of an increase in the permeability of bronchial epithelial cells (Leino et al., 2013) 
and the promotion of a rapid and robust release of early innate mediators and prolonged Th2 
inflammation (Kouzaki et al., 2009; Boitano et al., 2011; Snelgrove et al., 2014). The above-
mentioned data support the need to further investigate the allergenic properties of A. 
alternata SPs. 
 
2.9. Non-IUIS A. alternata allergenic proteins 
Five other A. alternata proteins (Alt a TCTP, Alt a NTF2, Alt a 2, Alt a 9 and Alt a 70 kDa) that 
were reported to be able to bind IgE from sensitized patients are not encompassed in the 
referred official allergen list, but they were already comprised in the Allergome database 
(http://www.allergome.org/). The translationally controlled tumor protein from A. alternata 
(Alt a TCTP) was characterized as an allergenic protein with the demonstrated ability to react 
with 4% (n=16) of A. alternata patients’ sera (Rid et al., 2009). A. alternata nuclear transport 
factor 2, Alt a NTF2, was described as a 13.7 kDa IgE-reactive protein that reacts with a low 
prevalence with sera proceeding from mold-sensitized individuals (Weichel et al., 2003). 
However, the sensitization prevalence in a population of patients sensitized to Alternaria was 
not studied. Reports respective to Alt a 2 allergen characterization are controversial. First, it 
was reported to be a major allergen with a sensitization rate of 61% among Alternaria-
sensitive patients (Bush et al., 1999). In a study performed by Asturias et al. (Asturias et al., 
2005), it was surprisingly found that none of the 42 A. alternata-sensitized patients’ sera 
reacted with Alt a 2. Alt a 9 was identified as a 42 kDa protein that bound IgE in 5% of 
patients (Achatz et al., 1995). For Alt a 2, Alt a 9 and Alt a 70 kDa proteins, the structural 
and biochemical functions are unknown. The last one was reported to induce skin reactivity in 





3. A. alternata allergens and cross-reactivity  
The allergen cross-reactivity phenomenon typically occurs when IgE antibodies that are 
originally raised against one allergen bind or recognize a similar protein from another 
allergenic source. Such recognition can trigger an allergic reaction or can be completely 
irrelevant for the patient. The clinical relevance of cross-reactivity depends on factors such 
as the host, exposure and implied allergen (Ferreira et al., 2004). Cross-reacting allergens are 
evolutionary conserved proteins that play vital functions and are therefore ubiquitously 
distributed in several biological sources (Hauser et al., 2010).  
The cross-reactivity of A. alternata with other airborne fungal species has been extensively 
described (Gupta et al., 2002), and there is evidence that a significantly high percentage of 
patients sensitized to A. alternata are poly-sensitized to more than one other fungal species 
and might also be sensitized to other environmental aeroallergen sources such as pollens, 
mites or even to food allergens (Mari et al., 2003). It is well known that the existence of 
cross-reactivity, particularly among different molds, may have implications for the diagnosis 
and treatment of fungal allergies (Crameri et al., 2009). In terms of diagnosis, it is common 
to observe that if a patient is primarily sensitized to highly conserved allergenic proteins, the 
patient’s serum could also give a positive result for a cross-reactive component from different 
allergenic mold species. This occurrence often complicates the identification of the primary 
sensitizer specie and results in defective management of the allergic disease. From both 
diagnostic and treatment perspectives, it is important that poly-sensitization resulting from 
allergen cross-reactivity be distinguished from co-sensitization to multiple allergenic sources. 
Immunologically, co-sensitization occurs when genuine sensitization to more than one 
allergen source is not due to cross-reactivity because it is not mediated by shared epitope-
specific antibodies (Canonica et al., 2013). Therefore, for each allergological relevant 
allergen source, clarifying the cross-reactive structures and genuine markers among the 
whole allergen array is necessary. 
Most A. alternata allergenic proteins are at least potentially cross-reactive across one or 
more species. As can be observed in Table 2, A. alternata possesses allergens that have their 
homologues in the 3 other genera that, together with Alternaria, are most commonly 
associated with the development of fungal allergy: Cladosporium, Penicillium and 
Aspergillus. 
The high identity scores of the alignments are strong evidence of the potential for the 
existence of IgE cross-reactions (Boywer et al., 2006). A sequence identity of at least 50% has 
been accepted as required for allergenic cross-reactivity (Aalberse, 2005); however, it can 
also rarely be detected when lowest sequence homologies are noticed. Differences in the 
amino acid sequence or structure, localization and/or amount of allergenic proteins reflect 






In relation to the major A. alternata allergen, the Allergome database 
(http://www.allergome.org/) includes a list of 171 Alt a 1-related proteins from several 
species of Alternaria and related taxa; however, to date, no evidence of IgE reactivity has 
been assessed for most of these molecules. In fact, most A. alternata-related taxa have been 
described to be associated mainly with the pathogenicity of plants and spoilage and the 
biodeterioration of fruits, feedstuffs and foods (Thomma, 2003) instead of environmental 
allergenic sources. Analysis of the molecular diversity of indoor Alternaria isolates in the USA 
revealed that species of Alternaria section Alternaria represented 98% (153 isolates), of 
which 137 isolates were assigned to A. alternata, 15 to the A. arborescens specie and a single 
isolate to A. burnsii (Woudenberg et al., 2015). Gutiérrez-Rodríguez et al. demonstrated that 
fungal species from the Pleosporaceae family, such as Stemphylium and Ulocladium, have a 
common allergen that shows a high level of cross-reactivity with Alt a 1 from A. alternata 
(Gutiérrez-Rodríguez et al., 2011). Given the scarce but existing evidence of Alt a 1 
homologue allergenicity and even with their expected low frequencies as environmental 
contaminants, evaluating the presence of other species that liberate Alt a 1-like proteins 
could contribute to the total allergenic Alt a 1 load to which atopic patients are exposed and 
may be an interesting task to consider further.  
The remaining A. alternata allergens are mostly phylogenetically conserved proteins that are 
recognized as cross-reactive fungal allergen classes that may cross-react with homologous 
protein from other fungal species but also from organisms from different phyla. Numerous 
reports present the mediation of the cross-reaction between minor A. alternata allergens and 
other fungal allergenic species (Breitenbach et al., 1997; Rid et al., 2009; Shankar et al., 
2005; Simon-Nobbe et al., 2000; Simon-Nobbe et al., 2008; Weichel et al., 2003). Among 
these, enolase (Alt a 6), for which cross-reactivity with Cladosporium, Saccharomyces, 
Candida, Aspergillus and Hevea brasiliensis was demonstrated (Breitenbach et al., 1997; 
Simon-Nobbe et al., 2000), is considered to be the A. alternata cross-reactive allergen with 
high allergological importance fundamentally in terms of diagnosis (Postigo et al., 2011). 
Recently, we undertook efforts to identify and characterize two new cross-reacting allergens: 
Alt a 14, a MnSOD, and Alt a 15, a vacuolar SP. In our experiments, these two allergens 
seemed to play a role in the cross-reactivity phenomena between A. alternata and other 
important allergenic molds, namely A. fumigatus and C. lunata. Specifically, it was found 
that Alt a 14 showed cross-reactivity with Asp f 6 (Gabriel et al., 2015c), an A. fumigatus 
allergen that, together with Asp f 4, is regarded as a specific marker for ABPA (Fricker-
Hidalgo et al., 2010; Hemmann et al., 1999). Some studies have referred to A. alternata as 
one of the potential etiologic agents of this hypersensitivity-mediated disease of the lower 
airways (Chowdhary et al., 2012; Singh and Denning, 2012; Chowdhary et al., 2014. Related 
to this, Jubin et al. observed a significant association of ABPA with a prior or concomitant 
sensitization to Alternaria and proposed that it may be the result of an allergenic cross-




Thus, because rAlt a 14 was also able to bind IgE from ABPA patient sera, it was suggested 
that this MnSOD could have important implications in A. alternata sensitization as a risk 
factor for the development of ABPA (Gabriel et al., 2015c). Moreover, it has been described 
that allergens belonging to the MnSOD protein family may cross-react also to homologous 
human MnSOD, which could contribute to the perpetuation of the inflammatory response in 
asthma (Crameri et al., 1996). 
Associations between sensitivity to airborne molds (A. alternata, C. herbarum and A. 
fumigatus) and food allergies, namely to mushrooms and spinach, have also been reported 
(Herrera et al., 2006). In a recent case report, a prior sensitization to A. alternata was 
associated with a severe food reaction to cross-reacting homologue mushroom proteins. A 
MtDH and a MnSOD from Agaricus bisporus mushroom with significant homology to Alt a 8 and 
Alt a 14, respectively, were identified as patient-specific IgE-binding proteins (Gabriel et al., 
2015b). 
Although a high number of fungal species shares IgE-binding homologue molecules, not all of 
them possess the same clinical importance. In fact, as an example, the well-recognized 
fungal pan-allergens belonging to the serine protease protein family are major allergens in 
several fungi, namely Aspergillus, Cladosporium, Curvularia, Penicillium, Rhodotorula and 
Trichophyton species; however, the A. alternata homologue (Alt a 15) presents a relatively 
low prevalence of recognition among A. alternata-sensitive patients. Quantitative differences 
rather than qualitative ones, e.g., the amount of allergen released, most likely explain why 
some of these proteins are minor or major allergens depending on the producer’s fungal 
species.  
Because a significantly high number of A. alternata-sensitized patients are poly-sensitized to 
other aeroallergens that are simultaneously present in high frequencies such as grass, olive, 
cat epithelia, Dermatophagoides and cypress (Katotomichelakis et al., 2012), the existence of 
cross-reactive or adjuvant phenomena must be considered. 
 
4. Alternaria allergens and their phylogenetic information 
Traditionally, fungal species are systematically categorized on the basis of their morphologic 
characteristics. However, in recent years, promissory phylogenetic approaches mainly based 
on sequence comparison of ribosomal RNA genes have emerged and have allowed a more 
advanced classification of fungi (Schoch et al., 2012). Simultaneously, it has been increasingly 
proposed that the knowledge of fungal biology and how it is evoluting may explain the 
antigenic nature of allergologically important fungal species.  
The evolutionary process seems to be responsible for the observation that a limited number 





system. In fact, the immune system of each atopic individual will recognize the foreign 
proteins existing in the surrounding environment, and the degree of the foreign nature of the 
recognized allergens is highly dependent on their evolutionary distance from human proteins. 
Accordingly, recently, Soeria-Atmadja et al. demonstrated that IgE sensitization patterns of 
individuals sensitized to fungi strikingly mirrors fungal phylogenetic relationships (Soeria-
Atmadja et al., 2010). These observations reflect the premise that more closely 
phylogenetically related fungi will have greater shared antigens.  
The existence of shared allergens across fungal species causing IgE cross-reactivity suggests 
that some genes coding for allergens recognized by IgE antibodies may be used as powerful 
phylogenetic markers that are useful to categorize fungi systematically and to identify 
proteins causing IgE cross-reactivity through the fungal kingdom. In this regard because A. 
alternata has been considered the main producer of fungal allergens, it is proposed that 
information on the evolution process of the gene coding for the allergen may be valuable in 
understanding the allergen importance in fungal biology and the stimulation of the allergic 
response. Generally, the molecular studies founded on fungal allergen proteins are limited 
but results are quite promising (Davolos and Pietrangeli, 2007). In one of their studies, Hong 
et al. found gene homologues of the major A. alternata allergen, Alt a 1, exclusively in 
Alternaria and taxonomically related species. In the same study, the authors used Alt a 1 as a 
molecular marker to produce phylogenetic trees of Alternaria and related taxa with high 
resolution and bootstrap supports (Hong et al., 2005). Indeed, the evolutionary distance of 
Alternaria and related other allergenic molds seems has led to the development of species-
specific proteins, such as Alt a 1, and this process explains the reason why it is the main 
primary sensitizer in a fungi-sensitized population and is widely considered to be a marker of 
sensitization to Pleosporaceae members (Postigo et al., 2011). Given its high phylogenetic 
content, the Alt a 1 gene and protein may be useful to unequivocally identify and detect a 
restricted group of fungal species (Gabriel et al., 2015d); this issue will be more extensively 
addressed below. In contrast, as described above, most A. alternata allergenic proteins are 
minor allergens that possess homologs across diverse fungal species. 
The taxonomic distribution of Alternaria allergens homologues may be highly correlated with 
sensitization and cross-reactivity data. Species phylogenetically related to A. alternata are 
likely to produce a similar allergen array and thus produce similar sensitization patterns 
whereas phylogenetically distant ones will only share ubiquitous cross-reactive molecules, 
thus explaining why the induced IgE sensitization data are less correlative. The IgE-based 
hierarchical tree proposed by Soeria-Atmadja et al. positioned A. alternata in the 
Pleosporales species cluster with the least similarity to other species of the same order 
(Soeria-Atmadja et al., 2010). Because this study included only a few Pleosporales members 
(Curvularia lunata, Stemphylium herbarum, Epicoccum purpurascens, Phoma betae and 
Setomelanomma rostrata) in which an Alt a 1-like protein is not described, the lower 




alternata mainly through Alt a 1. Future similar studies including a higher number of fungal 
species, namely those that are phylogenetically close to A. alternata, should be performed. 
This will allow obtaining the complete pattern of association between fungal molecular 
systematic and IgE sensitization data and ascertaining the value of Alt a 1 and other cross-
reactive fungal components in the delineation of a hierarchical organization among allergy-
related fungi. 
To establish complete phylogenetic analyses conducted on gene coding for allergens 
recognized by IgE antibodies and fully correlate the data with the immune system’s response 
displayed in fungi-sensitized individuals, research on allergenic protein homologues existing 
across fungal species is critical.  
 
5. Exposure to A. alternata allergens and its assessment 
Airborne measurement of mold exposure showed that increased atmospheric levels of fungal 
spores are linked to severe manifestations of respiratory allergic responses, occurrence of 
hospital admissions and deaths related to asthma (Targonski et al., 1995) 
The threshold Alternaria count in the air necessary to elicit allergic symptoms has been 
estimated to be 100 spores/m3 (Ricci et al., 1995). Compared with the concentration 
associated with the onset of allergenic symptoms for Cladosporium spores (3000 spores/m3) 
(Gravesen, 1981), that with Alternaria are the most widespread mold spores found in 
aerobiological surveys, the potent allergenicity of Alternaria is clear. This is in agreement 
with a previous study, where the comparison between sensitization to fungi with 
corresponding fungal spore counts found in the same environment showed that Alternaria 
presented a significantly higher score for sensitization (Beaumont et al., 1985). 
Knowledge of the aerodynamic characteristics and distribution of allergens and how and when 
exposure is increased is essential to try to establish relationships between allergen exposure 
and specific immune responses. Alternaria distribution is reported to be related to the 
geographic area, season, atmospheric condition and time of day (Rotem, 1994). Given that 
Alternaria species are prevalent phytopathogens, the concentration of allergenic airborne 
spores can also be linked to the release of spores from infected plants; thus, areas where 
agricultural activities are prevalent may be conducive to the environmental dissemination of 
allergenic A. alternata spores (Corden et al., 2003). 
Fungal exposures differ from prevalent environmental allergens, such as pollens, both in their 
quantity and in the duration of exposure to the allergenic source. In fact, airborne spore 
counts are often 1000-fold higher than pollen counts (Salvaggio et al., 1971), and a prolonged 
intense exposure to Alternaria spores normally occurs for months whereas pollen exposure 





It has been documented that asthmatic patients sensitized to Alternaria tend to suffer a more 
severe outcome during the late summer and early autumn (Chakrabarti et al., 2012; Canova 
et al., 2013), when the highest Alternaria spore counts are recorded (Rodríguez-Rajo et al., 
2005; Segvic and Pepeljnjak, 2006). Pulimood et al. found that epidemic thunderstorm-
related asthma is strongly associated with Alternaria species sensitivity and fragmentation of 
Alternaria spores results in easily breathable allergenic fragments. A high concentration of 
fungal spores, their transportation over large distances and other environmental factors that 
might contribute to bronchial hyper-responsiveness are associated with thunderstorms, such 
as ozone and a sudden reduction of temperature, and may explain the association. Because 
Alternaria species grow on cereals, it has been proposed that the farming practice 
contributes to increasing fungal spore levels (Pulimood et al., 2007). Global climatic change 
and CO2 concentration also appear to stimulate A. alternata sporulation and total antigen 
production (Wolf et al., 2010), consistent with the increase in the prevalence of allergies and 
asthma severity (Beggs and Bambrick, 2005).  
The presence of A. alternata allergen indoors has also been detected, namely colonizing in 
textile home stuffs such as carpets and bedding (Peters et al., 2008). In a US Indoors survey, 
the prevalence of symptomatic asthma was strongly correlated with A. alternata counts in 
the dust samples of patients’ homes (Salo et al., 2006).  
Because of the significant negative effects of A. alternata on human health and plants, the 
correct detection of A. alternata and its allergens is of great importance not only in the 
clinical setting but also in environmental, epidemiological and plant pathology studies. 
Several strategies have evolved to sample, identify and interpret exposure to fungi (Tovey 
and Green, 2005). The traditional methods of fungi identification and exposure evaluation are 
based on readily observable morphological features and spore counts (Guarro et al., 1999). 
The delineation of the Alternaria species is complicated by methods that have several 
associated limitations; these methods are time consuming, laborious, and they are not always 
reliable because they require the skills of a trained person.  
Recently, the epidemiological information obtained by traditional methods has been actively 
used to protect and enhance the quality of life in the sensitized/allergic subjects, though 
much work is needed in this field. Several protein- and DNA-based methods have merged and 
are considered useful tools for monitoring fungal exposure levels in a given indoor or outdoor 
environment. They can be performed on a large number of samples, often quickly and 
without the need of technical skills in mycological techniques. 
Protein-based methods include immunoassays such as enzyme-linked immunosorbent assays 
(ELISA) that use polyclonal or monoclonal antibodies to quantify A. alternata antigens. 
Currently, some ELISA kits are commercially available for the specific detection and 




interaction between antibodies and the specific allergens, and the possibility of cross-
reactivity with other nontarget proteins, namely homologues proteins from other sources, can 
lead to false-positive results. The main advantages of immunochemical assays such as ELISA 
are that they provide quantitative results and allow direct assessment of the allergen with a 
low set-up cost, moderated running time, and no special requirements for expert knowledge.  
Recently, Meng et al. found no significant difference in the detection rate of Alternaria 
between asthmatic and non-asthmatic homes by either spore counting or cultivable airborne 
detection (Meng et al., 2012). However, in a previous cross-sectional study, a polyclonal anti-
Alternaria antibody assay was successfully employed to detect Alternaria allergens in US 
homes; exposure to A alternata allergens in US homes has been observed to be associated 
with active asthma symptoms (Salo et al., 2006). The same assay allowed ascertaining that 
Alternaria antigen levels are influenced not only by regional and housing characteristics but 
also by residents’ behavior (Salo et al., 2005). The use of a monoclonal antibody-based ELISA 
confirmed that risk of respiratory symptoms in patients sensitized to A. alternata was 
significantly correlated with atmospheric Alt a 1 levels (Feo Brito et al., 2012). Capture ELISA 
was also described as a very sensitive, specific and reproducible assay for Alt a 1 detection in 
dust samples collected in poultry farms (Prester and Macan, 2010). 
Alternatively, development of DNA-based methods has enabled more reliably quantifying 
fungal species. Several detection and quantification PCR-based methods with acceptable set-
up costs and running times have emerged. Given its highly variable content, the large number 
of copies per cell and deposited sequences in international databases, Internal Transcribed 
Spacer (ITS) regions of the rRNA gene have been utilized as a target for assessing the fungal 
diversity in environmental samples (Rittenour et al., 2012). The main advantages of such 
molecular techniques are their specificity and minimal susceptibility to cross-reactivity 
phenomena because the chosen target sequence can be adapted from target allergen-
encoding sequences to species-specific DNA markers. Despite the advantages of DNA-based 
methods, PCR is still much contested because when detecting a gene encoding for an 
allergen, it does not necessarily imply its expression. Consequently, the results obtained by 
DNA detection do not account for the actual allergenic potential. However, the same happens 
with some, if not most, ELISA tests that do not necessarily detect the allergenic proteins but 
rather detect species-specific protein markers. In fact, the detection of a molecular marker 
gives indirect information regarding the allergenic potential, but provides evidence of the 
presence of the allergenic ingredient. 
A recent molecular study demonstrated that Alt a 1 can be used as a marker to successfully 
detect allergenic and pathogenic Alternaria and related taxa by PCR (Gabriel et al, 2015d). 
The PCR system using a primer set that was designed based on nucleotide conservation of Alt 
a 1-encoding sequences was able to detect all of the Alt a 1-producing species that were 





botryosum). In contrast, the use of a second primer set, previously used by other authors for 
the production of recombinant Alt a 1, allowed the detection of the closely taxonomically 
related species A. alternata and A. tenuissima.  
 
6. Allergen based-component diagnosis: a new era of Alternaria allergy 
diagnosis  
It is now generally accepted that the diagnosis of an allergy must be based on the clinical 
history of symptoms and on confirmative assays that may include the determination of 
allergen specific IgE antibodies by skin prick tests, laboratory-based in vitro analyses and/or 
provocation tests.  
According to a large Pan-European GA(2)LEN skin prick test study (Bousquet et al., 2009), an 
Alternaria extract should be included in the minimum standard battery of test inhalant 
allergens that are used to appropriately assess sensitization across Europe (Table 3). 
The combination of skin prick tests and determination of allergen-specific IgE levels in the 
serum is currently recommended for a reliable assessment of Alternaria sensitization. In 
diagnosis investigations, complex crude extracts are widely used. However, there are several 
limitations associated with the use of whole complex extracts that include the presence of 
irrelevant molecules and potentially highly cross-reactive allergens, the limited 
representation of some allergens and the well-documented variability between preparations 
of crude extracts (Shreffler, 2011). This could be the origin of the significant low concordance 
between SPT and serum IgE test results for Alternaria (O’Driscoll et al., 2009).  
Some studies investigating the biochemical and immunological content of commercially 
available Alternaria skin prick test solutions found high variability with respect to their 
protein, antigen and allergen contents (Kespohl et al., 2013; Esch, 2004; Vailes et al., 2001). 
Many factors attributed to the different steps of fungal extract production could be 
responsible for an inconsistent skin test preparation, which can result in an erroneous 
diagnosis. The use a specific mold strain and growth conditions preferred by the 
manufacturers is considered to be the first source of variation. Then, different extraction 
methods, with or without additives and final allergen quantification systems are also likely to 
be potential sources of variability (Kespohl et al., 2013,Sáenz-de-Santamaría et al., 2006; 
Portnoy et al., 1993). Recently, Twaroch et al. observed that Alternaria strains, media 
nutritional components and growth periods have an enormous impact on the presence of IgE-
binding proteins in the final extract (Twaroch et al., 2015). With regards to the most 
clinically relevant Alternaria allergen, it was demonstrated that Alt a 1 expression is highly 
dependent on fungal growing time, cultivation media (Ibarrola et al., 2004) and strain 




methods based on extracts obtained from related and non-related allergenic sources where 
the existence of cross-reactive allergens is well known results in difficulty in identifying the 
primary sensitizer (Crameri, 2011); therefore, no discrimination is allowed between cross-
reactivity and co-sensitization. 
To overcome crude extract-based diagnosis limitations, molecular or component-resolved 
diagnosis (CRD) using individual recombinant or native allergenic molecules tested on a 
florescence enzyme immunoassay (ImmunoCAP) or a microarray-based assay platform are now 
widely available in Europe (Shreffler, 2011). The availability of high-quality recombinant 
allergens by the recent advances in recombinant DNA technology for allergen research has 
allowed definition of individual sensitization profiles and an understanding of the nature of 
sensitization as well as noted makers of severity, persistence or cross-reactivity. Thus, more 
informed choices can be made regarding strategies for allergen-specific immunotherapy 
(Cromwell et al., 2011).  
To date, only two allergens (rAlt a 1, rAlt a 6) are commercially available for the molecular 
diagnosis of an Alternaria allergy. It has been currently accepted that the use of the species-
specific Alternaria allergen, Alt a 1, in molecular diagnosis, indicates a genuine sensitization 
to A. alternata, even if close homologue allergens might occur across the fungal kingdom 
(Twaroch et al., 2012). However, in the absence of sensitization to Alt a 1, the application of 
an individual A. alternata allergen with known cross-reactivity can improve diagnostic 
sensitivity, thereby permitting the identification of cross-sensitization and allowing the 
unequivocal definition of primary sensitizers in poly-sensitization cases. 
In a preliminary study, the use of two recombinant molecules, Alt a 1 and Alt a 6, by skin 
prick test seemed to correctly diagnose Alternaria sensitization in 7 tested subjects (Unger et 
al., 1999). Asturias et al. observed that replacing A. alternata extracts with either natural or 
recombinant Alt a 1 forms seemed to be sufficient for a reliable diagnosis of Alternaria 
sensitization (Asturias et al., 2005). Recently, Postigo et al. revealed that 2 of the 30 A. 
alternata allergic-patients did not react to Alt a 1 or Alt a 6 but did react to a potentially 
cross-reactive MnSOD, now officially named Alt a 14; according to the authors, Alt a 14 should 
be included in the molecular diagnosis allergen array (Postigo et al., 2011). 
It is hoped that the identification and characterization of the whole array of Alternaria 
allergens and new techniques based on allergenic protein cloning will allow the preparation 
of better quality test solutions and improve Alternaria allergy diagnoses.  
The most important steps to achieve an effective therapy for a fungal allergy are the 
accurate diagnosis and exposure assessment to A. alternata and its individual components. 
Because A. alternata is mainly an outdoor aeroallergen, its avoidance as a preventive 
therapeutic measure is difficult to achieve; however, some cautions, especially at home, may 






Compared to other common environmental allergenic sources, fungi are reported to be 
neglected and underestimated. As A. alternata allergies continue to rise, enabling research 
on the role of this fungal species and its allergenic components, particularly in asthma, makes 
sense. Establishing correlations of A. alternata exposure and allergic symptoms remains 
problematic. It is critically important to adopt a multidisciplinary approach using both 
epidemiologic and molecular tools to accurately evaluate the exposure trends to A. alternata 
and its individual allergens and to determine the potential health effects. 
As presented in this review, A. alternata allergens may be considered potent markers of 
phylogeny, sensitization and exposure. Complete characterization of fungal allergens and the 
analysis of a distinct pattern of allergenic species distribution will aid in understanding and 
predicting cross-reactivity and improving allergy diagnostic methodologies. Moreover, an 
understanding of the phylogenetic content of unique and shared allergens will provide insights 
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The link to World Health Organization and International Union of Immunological Societies(WHO/IUIS) Allergen Nomenclature Sub-














Heat shock proteins 70 Alt a 3 
Pen c 19 





Ribosomal protein P2 Alt a 5 
Fus c 1 
Cla h 5 







Enolase Alt a 6 
Cla h 6 
Asp f 22 
Pen c 22 
Cur l 2 











Flavodoxin, YCP4 protein Alt a 7 Cla h 7 Cladosporium herbarum 9.4 e-61 
Mannitol dehydrogenase Alt a 8 Cla h 8 Cladosporium herbarum 6.6 e-91 
Aldehyde dehydrogenase Alt a 10 Cla h 10 Cladosporium herbarum 5.9 e-168 
Acid ribosomal protein P1 Alt a 12 
Cla h 12 
Pen cr 26 
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Serine protease Alt a 15 
Cur l 4 
Cla h 9 
Pen o 18 
Asp f 18 
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Rho m 2 
Tri r 2 
Pen ch 13 
Asp v 13 



























Asp o 13 
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Table 3. Skin prick test standard allergen battery to assess sensitization across Europe  suggested by 






















































The main aim of this work was to broaden the knowledge on the repertoire of allergenic 
proteins produced by Alternaria alternata, the main inducer of severe asthma caused by 
fungi, and use such knowledge to improve prediction, diagnosis and understanding of the 
human immunological responses to fungal allergens. 
The development of specific molecular tools for the unequivocal assessment of the exposure 
to A. alternata is critical in evaluating the epidemiology as well as in predicting the risk and 
severity of allergic respiratory disorders caused by this fungal specie. Likewise, the 
identification and characterization of the complete panel of clinically relevant allergens of A. 
alternata and the definition of individual allergen sensitization patterns are crucial for 
achieving improved understanding, diagnosis and management of the fungal allergic diseases. 
Particularly, the availability of identified allergens as recombinant proteins will assist the 
improved component-resolved-diagnosis of fungal allergy and allow for allergen biochemical 
and immunological characterization. Moreover, the sequence and structural comparison of 
individual allergens with homologues from other allergenic species as well as the study of IgE 
cross-reactivity will help to clarify diagnostic problems that are associated with the poly-
sensitization phenomena, a common and relevant general clinical feature in the mold allergic 
population.  
  
With these global aims in mind, the development of the work followed the subsequent tasks: 
 
a) Demonstrate that the phylogenetic information of encoding gene of the A. 
alternata major allergen, Alt a 1, can be used as a molecular marker suitable to 
be applied in assessment of exposure to Alternaria and related species. 
 
b) Cloning and production of a manganese-dependent superoxide dismutase and a 
serine protease from A. alternata as recombinant molecules. 
 
c) Assessment of sequence homologies and IgE cross-reactivity between the newly 
identified A. alternata allergenic proteins and allergen homologues from other 
fungal species. 
 
d) Practical application of the allergen repertoire of A. alternata to explain clinical 
sensitization data displayed by patients presenting allergic symptoms that seem 
to be associated to a primary sensitization to A. alternata. 
 
e) Recognition by the WHO/IUIS Allergen Nomenclature Sub-committee of the newly 
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Abstract
Alt a 1 has been recognized as the most important allergen produced by the Pleospo-
raceae family and is a risk factor for asthma development and/or exacerbation. The aim of
this study was to develop a detection tool that is highly specific for species that produced
airborne Alt a 1. Based on the highly conserved internal nucleotide region of the several
Alt a 1 sequences that are available in GenBank, a pair of primers (Alta1CF/Alta1CR)
was designed. A set of primers used by other authors for the production of recombinant
Alt a 1 (A21F/A21R) was also tested. The molecular analyses were based on the poly-
merase chain reaction (PCR) amplification and sequencing of the cDNA that was obtained
from thirteen common fungal species. The PCR system that utilized Alta1CF/Alta1CR was
highly specific, sensitive, and was able to detect an amplicon of approximately 180 bp
from Alt a 1 and Alt a 1-like encoding genes from A. alternata, A. tenuissima, A. infectoria,
U. botrytis, and S. botryosum. In contrast, the A21F/A21R primers were specific for the
very close taxonomically related species A. alternata and A. tenuissima. Thus, this rapid,
sensitive, and specific detection tool can be used to assess Alt a 1 exposure levels and
to inform the implementation of the appropriate public health measures.
Key words: Alt a 1, Alt a 1 homologues, Alternaria alternata, allergen monitoring, amplification.
Introduction
Moulds occur in outdoor and indoor environments, where
they grow on many different substrates, and are described
as significant causes of invasive infections and respiratory
allergic diseases in humans [1,2]. Fungal exposure assess-
ments have traditionally relied on species-level identifica-
tion using indirect methods that are based on spore or
fungal colony count and culture techniques [3]. These
636 C© The Author 2015. Published by Oxford University Press on behalf of The International Society for Human and Animal
Mycology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com
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methodologies are generally laborious and time-consuming,
and it can be difficult to establish or exclude a fungal con-
tamination and its eventual association with a disease. To
overcome these limitations and to address the increasing in-
cidence of fungal allergic diseases worldwide, it is necessary
to develop faster and more accurate alternative methods for
the identification of fungal contamination. Molecular sys-
tematic and evolutionary approaches for mould identifica-
tion have emerged in recent years [4,5].
Alternaria spp. are among the most common fungi, and
the genus includes numerous species that are pathogenic
to a variety of plants, including cereals, oil-yielding crops,
spices, vegetables and fruits [6,7]. Furthermore, A. alter-
nata spores are one of the most frequently identified fungal
spore types in the atmosphere, and this specie is one of
the most important fungal allergen producers [8–10]. In
particular, the major allergen, Alt a 1 of A. alternata has
been demonstrated to be the most important allergen that is
produced by the airborne allergenic moulds [11–13]. Sensi-
tization to this allergen is considered an important marker
for predicting the risk and severity of respiratory symptoms
[14,15]. Several other species of Alternaria and related gen-
era have been described to possess Alt a 1 gene homologues
[16], and allergenicity and cross-reactivity with some Alt a
1-like proteins from Stemphylium botryosum and Ulocla-
dium botrytis have been reported [17].
Detection of Alt a 1 and its homologues, by investigating
the conserved genes that encode the allergen instead of the
species-level identification of Alternaria, could be consid-
ered an optimal tool for establishing the risk of respiratory
symptoms in individuals who are sensitized to Alt a 1 or Alt
a 1 homologues. With this in mind, we conducted molecular
studies to demonstrate that Alt a 1 can be used as a marker
to successfully detect allergenic and pathogenic Alternaria
and related taxa by PCR.
Materials and method
Fungal strains and culture conditions
The A. alternata strains CBS 104.26, CBS 154.31, CBS
106.24, CBS 105.24 (Centraalbureau von Schimmelcul-
tures, Utrech, the Netherlands) and FMR 3292 (Laboratory
of Mycology, Rovira Virgili University, Tarragona, Spain),
A. tenuissima FMR 5813, A. infectoria CBS 210.86, Ulo-
cladium botrytis FMR 5819, Stemphylium botryosum FMR
3952, Drechslera tritici-repentis CBS 265.80, Pyrenophora
teres f. teres CBS 123932, Epicoccum nigrum CBS 684.83,
Curvularia lunata FMR5790, Aspergillus fumigatus AF54,
Penicillium chrysogenum PC4 (Municipal Institute for
Medical Research, Autonomous University of Barcelona,
Spain), Trichophyton mentagrophytes CBS 120672 and
Fusarium solani CECT 20232 (Spanish type Culture collec-
tion, University of Valencia, Spain) were used in this study.
All of the fungal strains were cultured in 100 ml Erlenmeyer
flasks containing 50 ml of Czapek broth medium at 25oC.
Mycelia from 5-day-old cultures were harvested by vacuum
filtration for RNA extraction. The A. alternata CBS 104.26
strain was also grown on Sabouraud dextrose agar plates
for 7 days at 25oC and used for A. alternata spore sus-
pension preparation. A. alternata spores were collected as
previously described by Otani et al. 1998 [18]. Then, the
spore suspension was counted using a hemacytometer, ad-
justed to a final concentration of 1 × 106 spores/ml and
10-fold diluted with sterile distilled water.
RNA extraction methods
Fungal mycelial mat was ground under liquid nitrogen with
mortar and pestle and 100 mg of pulverized sample was
resuspended in 1 ml of Trizol reagent (Invitrogen, Carlsbad,
CA). Total RNA was extracted from the mycelia according
to the instructions provided by Trizol’s manufacturer.
On the other hand, a bead beating method was used
for extraction of total RNA from A. alternata spore sus-
pensions (1 × 101 to 1 × 106 spores/ml). Two hundred
microliters of each spore dilution was placed into a 2 ml
extraction tube containing 600 mg of 0.1 mm glass beads
and 500 μl RLC buffer (provided with the RNeasy R© Plant
Mini Kit, Qiagen, Germany) that was supplemented with
β-mercaptoethanol. The tubes were quickly frozen in liq-
uid nitrogen and placed on ice for 1 min. Then, the spore
disruption was achieved by processing samples with the
Mikro-Dismembrator U (B. Braun Biotech International,
Melsungen, Germany) at 2000 rpm for 1 min, 5 min, and
10 min. The samples were immediately cooled down by
placing them in ice in between each bead-beating step for
up to 5-min intervals. Then, supernatants were obtained by
centrifugation for 2 min at 13000 rpm, and RNA was ex-
tracted using RNeasy kit according to the manufacturer’s
fungi protocol. The final elution step was carried out with
30 μl of sterile distilled water and from this volume, 11 μl
was used for reverse transcription. The RNA quality was
analyzed with 1.2% agarose gel electrophoresis.
cDNA synthesis, primer design, and PCR
amplification
Twenty microliter reverse transcription reactions were car-
ried out with the RevertAid First Strand cDNA Synthesis
Kit (Fermentas, St. Leon-Rot, Germany). A pair of primers
was manually designed based on the highly conserved inter-
nal nucleotide region of the several Alt a 1 gene sequences
that are available in the GenBank database (Table 1)
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Table 1. Genbank accession numbers for Alt a 1 sequences
used in multiple alignment analysis.





















































Table 2. Sequence of PCR primers used in this study.





Note: H = A, T or C; R = A or G, S = C or G; Y = T or C
following alignment with the Clustal W analysis program.
The primer pair, A21F/A21R, used by Asturias et al.
[12] to produce recombinant Alt a 1, was also tested.
Table 2 summarizes the primer sequences. PCR reactions
were performed with Expand High Fidelity System (Roche,
Mannheim, Germany) and 10 μl of cDNA as the template.
The PCR product was purified with electrophoresis on an
agarose gel, subcloned into the pJET1.2/blunt vector, and
transformed into Escherichia coli DH5 alpha competent
cells. The plasmid DNA was purified, and the nucleotide
sequence of the cDNA insert was determined. Sequencing
reactions were performed using the BigDye Terminator v.3
sequencing kit (Applied Biosystems) according to the man-
ufacturer’s specifications and were run in an ABI 3130XL
sequencer (Servei de Genòmica, Universitat Autònoma de
Barcelona). The amplicon sequence identity was confirmed
with NCBI BLAST.
Results
Multiple alignment of the Alt a 1 gene sequences al-
lowed us to identify a core conserved region for the
Alta1CF/Alta1CR primer set design (Fig. 1). Clustal W re-
sults revealed that the sequence identities of the Alt a 1 gene
and its homologues ranged from 69.4% to 100%. Addition-
ally, of the approximately 510 nucleotides that constitute
the Alt a 1 genes, 158 were 100% conserved between all
Alternaria and related species. Eighty-three of these invari-
ant sites were located in the gene region that was covered
by the Alta1CF/Alta1CR primer set (Fig. 1). The primers
were designed so that the amplified region would include
the coding information for the two most important Alt a 1
immunoglobulin E (IgE)-binding linear epitopes (K41-P50
and Y54-K63) that were previously described by Kurup
et al. [19]. The Alta1CF/Alta1CR primer specificity was
assessed by analyzing the cDNA that was obtained from
13 fungal species, including 9 species that belong to the
Pleosporaceae family (A. alternata, A. tenuissima, A. infec-
toria, U. botrytis, S. botryosum, D. tritici-repentis, P teres
f. teres, E. nigrum, and C. lunata) and 4 that were non-
Pleosporaceae allergenic relevant species (A. fumigatus, T.
metagrophytes, F. solani, and P. citrinum). Additionally,
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to eliminate the influence of the inter-strain variability, 5
different A. alternata strains were also included. The PCR
amplification reactions with the Alta1CF/Alta1CR primer
pair produced a single PCR product of approximately 180
bp for the A. alternata, A. tenuissima, A. infectoria, U.
botrytis and S. botryosum species. This amplicon was also
obtained for all five A. alternata strains (Figs 2A and 3). Se-
quence analysis of the 180 pb amplicons that were obtained
by this assay revealed sequence identities that ranged from
87.3% to 100%.
Furthermore, the PCR amplification experiments with
the A21F/A21R primer set produced the expected 390 bp
amplicon in the A. tenuissima strain and the five A. alternata
strains, but no PCR product was detected for the other
species that were included in this study (Figs 2B and 3).
Additionally, to determine the PCR sensitivity (the low-
est A. alternata counts detected) the A. alternata spore sus-
pensions that ranged from 1 × 101 to 1 × 106 spores/ml
were used. This system included a bead-beating pro-
cess for breaking up the spores in the sample and the
Alta1CF/Alta1CR primer set to amplify the fungal RNA
that was retrieved from spore breakage. The lowest spore
counts detected were 2 × 103 A. alternata spores, which
existed in the 200 μl of 1 × 104 A. alternata spores/mL
suspension that was used for RNA extraction (Fig. 4). This
corresponded to an RNA detection limit of approximately
Figure 1. Nucleotide identity found by multiple alignment of Alt a 1 nucleotide sequences of Alternaria and related species. The higher bar indicates
higher homologies. Nucleotides that 100% identical (invariant) among all Alt a 1 sequence are boxed. The primer positions are shown by arrows.
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Figure 2. Electrophoretic analysis of Alt a 1 PCR products obtained using (A) Alta1CF/Alta1CR and (B) A21F/A21R primers from different allergologically
important fungal species. Samples in lanes correspond to: Alternaria alternata strain CBS 104.26 (1), Ulocladium botrytis FMR 5819 (2), Stemphylium
botryosum FMR 3952 (3), Drechslera tritici-repentis CBS 265.80 (4), Pyrenophora teres f. teres CBS 123932 (5), Epicoccum nigrum CBS 684.83 (6),
Curvularia lunata FMR 5790 (7), Aspergillus fumigatus AF54 (8), Trichophyton mentagrophytes CBS 120672 (9) and Fusarium solani CECT 20232 (10),
Penicillium chrysogenum PC4 (11), negative control (12 and 19), Alternaria alternata strains CBS 154.31 (13), CBS 106.24 (14), CBS 105.24 (15) FMR
3292 (16), A. infectoria CBS 210.86 (17), A. tenuissima FMR 5813 (18), GeneRulerTM DNA Ladder Mix (M).
Figure 3. Position of the primers A21F, A21R, Alta1CF and Alta1CR in the Alt a 1 gene (534 pb) and scheme of amplicons obtained by PCR amplification
using cDNA from A. alternata, A. tenuissima, A. infectoria, U. botrytis and S. botryosum.
Figure 4. Electrophoretic analysis of Alt a 1 PCR products obtained using
Alta1CF/Alta1CR primer set from 10-fold dilutions of an A. alternata
spore suspension. Samples in lanes correspond to Alternaria alternata
strain CBS 104.26 spore suspensions adjusted to a concentration of: 1
× 101 (1), 1 × 102 (2), 1 × 103 (3), 1 × 104 (4), 1 × 105 (5), and 1 × 106
(6) spores/ml; Negative control (7); positive control (8) and GeneRulerTM
DNA Ladder Mix (M).
366 spore per PCR reaction. All of the amplified prod-
ucts were purified and sequenced. The sequencing results
and BLAST analysis indicated that the fragments indeed
matched the Alt a 1 DNA sequences.
Discussion
The foreign nature degree of the proteins that we encounter
in the surrounding environment is highly dependent on their
evolutionary distance from human proteins. Therefore,
the human immune response can mirror the phylogenetic
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relationships of allergenic sources. Particularly, among the
allergologically relevant fungal species, the evolutionary
process seems to be responsible for the observation that a
limited number of species produce a specific allergen that is
highly recognized by the human immune system. Addition-
ally, a close relationship between molecular fungal system-
atic and fungal IgE sensitization was recently reported [20].
With regards to Alt a 1, the cross-reactivity phenomenon
that is triggered by the presence of multiple closely related
Pleosporaceae allergen homologues [17] is one explanation
for the clinical observation that the majority of patients dis-
playing A. alternata allergies are polysensitized to several
fungal species. With this in mind, to correctly assess the
respiratory allergenic disorders epidemiology that is caused
by Alternaria and its related species, it will be important to
detect all Alt a 1 homologues that are allergenic and poten-
tially cross-reactive. Here, we took advantage of the phy-
logenetic information that was obtained from investigating
the nucleotide conservation of the genes encoding the Alt
a 1 homologues and developed a method for detecting the
presence of Alt a 1 with a PCR-based system.
A multiple alignment analysis of the different fungal Alt
a 1 nucleotide sequences allowed for the identification of a
highly conserved sequence region. Primers with the poten-
tial to amplify all Alt a 1-encoding sequences were designed
for this conserved region. These oligonucleotides were ap-
plied in the PCR experiments using cDNA as the ampli-
fication target. The use of cDNA instead of gDNA was
considered more suitable because it is a better indicator of
cell viability, which allows for the specific detection of vi-
able fungal spore producers of Alt a 1-like proteins. Of the
13 fungal species included in the study, cDNA that was
prepared from five species (A. alternata, A. tenuissima, A.
infectoria, U. botrytis, and S. botryosum) generated a 180
bp amplicon in the PCR assay. These results suggest that
genes encoding Alt a 1 (and its homologues) are restricted to
specific groups of fungi including Alternaria and its related
species. These observations are in accordance with previous
studies [16]. These findings also confirmed that the studied
Alt a 1 conserved “core” region is shared by all of the
species in which an Alt a 1-like gene was described. The
detection system sensitivity of the pure A. alternata spore
samples was 366 spore RNA equivalents per PCR reaction,
which corresponded to 1 × 104 spores/ml of sample.
A study using Alt a 1 synthetic peptides identified two
linear epitopes (K41-P50 and Y54-K63) that were shown to
strongly bind IgE from the sera of patients who were allergic
to A. alternata [19]. Recently, Chruszcz et al. demonstrated
that these epitopes were surface exposed in the Alt a 1
three-dimensional structure and, therefore, they were easily
accessible for interactions with the antibodies [21]. Based
on these reports and because the conserved region of the
Alt a 1 gene that was amplified by the Alta1CF/Alta1CR
primers includes the nucleotide sequences that encode these
two epitopes, we suggest that the fragment detected by this
system is not only a phylogenetic marker but also an Alt a 1
allergenicity marker. In the DNA amplification assays with
the A21F/A21R primers, only a 390 bp PCR product was
obtained from A. alternata and A. tenuissima cDNA. This
observation may be explained by the high homology that
is shared between the A. alternata and A. tenuissima Alt
a 1 genes due to their close phylogenetic relationship. The
A21F/A21R primers may be a suitable alternata species-
group-specific primer pair for screening fungal species in
environment monitoring. Further studies using air and/or
dust samples are required to validate the applicability of the
method proposed by this work. Nevertheless, the most com-
mon Alt a 1-producing species were included in this study,
suggesting that this PCR system may be a valuable tool for
Alt a 1 allergen detection. Moreover, because Alternaria
species are important pathogens of a wide range of fruits
and vegetables [6,7], and because Alt a 1 is a competitive in-
hibitor of plant defense proteins belonging to the PR5-TLP
family, and it is most likely a fungal infection pathogenicity
marker [22], this technique may also be a valuable tool for
the identiffication of Alt a 1-producing fungal species and as
a quality and biosecurity marker for food stuffs. Our find-
ings are in line with some reports that have demonstrated
the applicability of PCR-based techniques and sequencing
assays that targeted the internal transcribed spacer (ITS)
region of ribosomal RNA genes and some species-specific
conserved genes for fungal species detection and identifica-
tion [23–25].
In summary, because Alt a 1 sensitivity is a compelling
epidemic asthma predictor, and although the environment
usually contains much higher A. alternata spore levels than
those of the other Pleosporaceae species that express an Alt
a 1-like protein, the detection of the total Alt a 1 levels,
independent of its fungal source, as proposed in this work,
may help to clarify the relationship between the inhaled
allergen and the patient’s allergic response.
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a  b  s  t  r  a  c  t
It is  well  known  that  Alternaria  alternata  presents  a  significant  level  of allergenic  cross-reactivity  with
several  other  phylogenetically  related  and  non-related  allergenic  moulds.  To  improve  the  molecu-
lar  diagnosis,  the identification  and  characterisation  of  all clinically  relevant  allergens,  including  both
species-specific  and  cross-reacting  proteins,  is required.  In this  study  we report  the  molecular  and
immunological  characterisation  of  the  A.  alternata  manganese-dependent  superoxide  dismutase  (Alt  a
MnSOD)  and  its cross-reactivity  with  Asp  f  6, a diagnostic  marker  allergen  in allergic  bronchopulmonary
aspergillosis  (ABPA).  The  cDNA  coding  for Alt a MnSOD  sequence  was isolated  by  RACE  and  PCR.  Alt  a
MnSOD  is a protein  of 191 amino  acids  that  presented  significant  homology  and  potential  cross-reactive
epitopes  with Asp  f 6.  The  recombinant  protein  was  produced  in  Escherichia  coli and  the  immunoreactivity
was  evaluated  in  patient  sera.  Immunoblotting  analyses  showed  that  seven  of  sixty-one  A.  alternata-
sensitised  patient  sera  and  two ABPA  patient  sera  reacted  with  the  recombinant  Alt  a  MnSOD.  The  native
counterpart  contained  in both  A.  alternata  and Aspergillus  fumigatus  extracts  inhibited  IgE binding  to  the
recombinant  molecule.  The  allergen  was named  Alt a  14  by  the  official  Allergen  nomenclature  subcom-
mittee.  Thus,  Alt  a 14  is  a  relevant  allergen  in A.  alternata  sensitisation  that  may  be  used  to  improve
diagnostic  procedures.  Evidence  of  cross-reactivity  between  Asp  f 6 and  Alt  a 14-recognition  by  ABPA
patient  sera  suggest  the  existence  of  an  Alt  a  14-mediated  mechanism  that,  similar  to  Asp  f 6, may  be
related  to the  pathogenesis  of  ABPA.
©  2015  Elsevier  GmbH.  All  rights  reserved.ntroduction
Fungi are recognised as important sensitisers and triggers of
espiratory allergies (Simon-Nobbe et al., 2008). Among the com-
on airborne fungal species, Alternaria alternata is one of the
rincipal species associated with allergic disease (Simon-Nobbe
t al., 2008; Bush and Portnoy, 2001; Bousquet et al., 2009; Mari
t al., 2003). Exposure and sensitisation to this mould have been
ncreasingly recognised as risk factors for the development and
Abbreviations: ABPA, allergic bronchopulmonary aspergillosis; Alt a MnSOD, A.
lternata manganese-dependent superoxide dismutase; sIgE, specific immunoglob-
lin  E.
∗ Corresponding author at: Department of Immunology, Microbiology and Para-
itology, Faculty of Pharmacy and Laboratory of Parasitology and Allergy, Lascaray
esearch  Centre, University of the Basque Country, Paseo de la Universidad 7, 01006
itoria, Spain. Tel.: +34 945013804/905.
E-mail  address: jorge.martinez@ehu.es (J. Martínez).
ttp://dx.doi.org/10.1016/j.imbio.2015.01.006
171-2985/© 2015 Elsevier GmbH. All rights reserved.persistence of asthma, asthma severity, and potentially fatal
asthma exacerbations (Salo et al., 2006; Black et al., 2000;
Kobayashi et al., 2009; Brito et al., 2012).
Among several allergens described in Alternaria, Alt a 1 has
been demonstrated to be the most important, being recognised by
approximately 80% of A. alternata-sensitised patients (Unger et al.,
1999; Morin et al., 2012; Asturias et al., 2005). Other fungi from
the Pleosporaceae family (Stemphylium, Ulocladium, Nimbya and
Embellisia) have been described to possess Alt a 1 gene homologues
(Hong et al., 2005). However, to date, evidence of allergenicity
and cross-reactivity with Alt a 1 from A. alternata has only been
reported for Stemphylium botryosum and Ulocladium botrytis Alt
a 1 homologues (Gutierrez-Rodriguez et al., 2011). Although in
addition to Alt a 1, 12 other proteins have been accepted by the
International Union of Immunological Societies (IUIS) as official A.
Alternata allergens (http://www.allergen.org), the clinical observa-
tions  do not appear to be completely explained by the previously
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uite complex, showing a significant level of cross-reactivity and
oly-sensitisation with several other phylogenetically related and
on-related moulds (Crameri, 2011; Katotomichelakis et al., 2012;
ostigo et al., 2011).
Recently,  Postigo et al. (2011) identified a new 24 kDa
gE-reactive protein from A. alternata, included in the manganese-
ependent superoxide dismutase (MnSOD) protein family. Other
ungal MnSODs have also been identified as important allergens in
spergillus fumigatus (Asp f 6) and Malassezia sympodialis (Mala s
1) (Lambou et al., 2010; Andersson et al., 2004). In particular, Asp
 6 has been widely described as an allergen that is strongly asso-
iated with allergic bronchopulmonary aspergillosis (ABPA) and
requently used as a tool to distinguish ABPA from fungal sensi-
isation (Fricker-Hidalgo et al., 2010; Schwienbacher et al., 2005).
In  the present study, we report the cloning, expression,
mmunologic  characterisation of the A. alternata MnSOD and its
ross-reactivity with Asp f 6.
aterials and methods
trains  and fungal extracts
A.  alternata strain CBS 104.26 (Centraalbureau von Schimmel-
ultures, Utrech, the Netherlands) and A. fumigatus strain AF54
Municipal Institute for Medical Research, Barcelona, Spain) were
sed. Fungal extracts were prepared as previously described by
artinez et al. (2006).
uman  sera
Sera  from sixty-one individuals sensitised to A. alternata were
elected according to a positive skin prick test (ALK-Abelló A.
lternata extract, >3 mm wheal diameter) and positive A. alternata-
pecific IgE (sIgE) levels (>0.35 kU/L).sIgE to rAlt a 1 and rAsp f 6
as quantitatively determined using the ImmunoCAPTM System
Phadia AB, Uppsala, Sweden). Additionally, one Dermatophagoides
teronyssinus-sensitised patient serum sample that was negative
or A. alternata- and A. fumigatus-specific IgE was used as a nega-
ive control. Two sera from patients with ABPA were also used. The
iagnostic features for both ABPA subjects were intradermal test
eactivity to A. fumigatus extract, an A. fumigatus sIgE level higher
han 10 kU/L, positive precipitins to A. fumigatus extract, central
ronchiectasis, positive sputum culture to A. fumigatus and positive
sp f 6 sIgE (>3 kU/L). All sera were acquired from our sera collection
C.0002774, registered in the Institute of Health Carlos III, Ministry
f Economy and Competitiveness, Government of Spain). Written
nformed consent to participate in the study was obtained from all
ndividuals. The study was approved by the local ethics committee
nd was conducted in accordance with the Declaration of Helsinki.
DNA cloning and sequencing
Total  RNA was extracted from the fungal mat  of 5-day-
ld A. alternata using TRIzol (Invitrogen, Carlsbad, CA), and
everse transcription was  performed using a RevertAid First
trand cDNA Synthesis Kit (Fermentas, St. Leon-Rot, Germany)
ccording to the manufacturers’ instructions. Degenerated primers
SODF (5′-GTCKCCGTGCAGCARGCSATCAAG-3′) and iSODR (5′-
TCCCACATRTCSAYRCCAAAGAC-3′) were designed based on the
ighly conserved nucleotides of the several available fungal
nSOD sequences in GenBank and used to amplify an internal
ragment of the Alt a MnSOD. The PCR product was puri-
ed, subcloned and sequenced. Then, full-length cDNA was
btained using Rapid Amplification of cDNA ends (RACE) as
reviously described by Tripathi et al. (2011). Products of
he RACE reactions were purified, subcloned and sequenced.
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New  primers, flSODF (5′-ATCATGGAGCTGCATCACAGCAAG-3′) and
flSODR (5′-TTGAGAGTGAATGCGTGTCTTTG-3′), were designed for
the full-length sequence, and cDNA was amplified, cloned and
sequenced.
Computational analysis and homology search
The Alt a MnSOD gene and deduced protein sequences were ana-
lysed and compared with those in the GenBank database and the
Structural Database of Allergenic Proteins (SDAP). Sequence align-
ments were performed using the ClustalW Analysis Programme
(http://searchlauncher.bcm.tmc.edu).
Theoretical protein parameters were calculated with the
ProtParam programme (http://web.expasy.org/protparam/).
The sequences were also analysed by Gene Runner software
(http://www.generunner.net/). The three-dimensional structure
of  the MnSOD from A. fumigatus (Asp f 6, Protein Database Bank
(PDB) code 1KKC) was used as a template to build the homology
model of the Alt a MnSOD. Monomeric and tetrameric molec-
ular models were generated using the programme ESyPred3D
(http://www.fundp.ac.be/sciences/biologie/urbm/bioinfo/esypred/
(Lambert et al., 2002). Visualisation of the models was performed
with the programme Swiss-Pdb Viewer (http://spdbv.vital-it.ch).
Expression of the recombinant protein
The open reading frame encoding Alt a MnSOD  was amplified
using gene-specific primers, i.e., a forward primer with an Nco I
(underlined) restriction site (5′-CCATGGATGAGCTGCATCACAGCA-
3′) and a 3′ reverse primer introducing a Hind III (underlined)
restriction site (5′-AAGCTTGATGGAAGCCTTGAGCTC-3′). Then, it
was cloned into the plasmid expression vector pBAD-TOPO
(Invitrogen) and transformed into One Shot® TOP10 Chemically
Competent Escherichia coli cells (Invitrogen). The cells were grown
at 37 ◦C in Luria–Bertani broth medium containing 100 g/ml
ampicillin to an OD600 nm of 0.5 and induced by treatment with
0.02% (w/v) l-arabinose for 4 h. Then, induced cells were pelleted
at 10,000 × g for 10 min  and lysed with B-PER bacterial protein
extraction reagent (Thermo Scientific, Rockford, IL, USA). After
inclusion bodies were solubilised using an inclusion body solu-
bilisation reagent, recombinant protein was  purified by affinity
chromatography using His PurTM Ni-NTA (Ni2+-nitrilotriacetate)
resin (Thermo Scientific). Eluted protein was  refolded by dialysis
against decreasing concentrations of urea and, finally, against Tris
buffer (25 mM Tris–HCl, 150 mM NaCl, pH 7.5).
SDS-PAGE and immunoblotting
Proteins  were separated by 12% SDS-PAGE gels. For
immunoblotting, proteins were transferred onto polyvinyli-
dene difluoride (PVDF) membranes (Bio-Rad, Hercules, CA, USA),
as described by Towbin et al. (1979). Briefly, the membrane was cut
into strips and incubated overnight with patient sera at 4 ◦C. Then,
bound IgE was  detected by incubation with mouse anti-human
IgE horseradish peroxidase (HRP) conjugate (Southern Biotech,
Birmingham, AL, USA). The blots were developed by the addition of
chemiluminescent reagents (ECL+, Amersham Biosciences, Bucks,
UK). To detect the [His]6-fusion protein, western blotting using an
anti-His-HRP antibody (Invitrogen) was  also performed.
For the immunoblotting inhibition assays, a serum sample from
a patient sensitised to A. alternata with positive immunoblotting
to rAlt a MnSOD was preincubated at 4 ◦C overnight with A. alter-
nata and A. fumigatus extracts (5 mg  protein/mL) or PBS. Then, the
inhibited sample was  tested for binding to rAlt a MnSOD blotted
onto a PVDF membrane.
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ig. 1. (A) The nucleotide and deduced aminoacid sequences of Alt a MnSOD (GenB
uperoxide dismutase signature is underlined. (B) Sequence alignment of Alt a Mn
1  from Malassezia sympodialis. Identical aminoacids exposed to the solvent (FSASA
ass spectrometry
The  26 kDa band, revealed by western blotting, was identified
y MALDI-TOF/TOF. The MALDI result was obtained in the form of
 MASCOT search chart.
pecific  IgE ELISA inhibition
The  serum of an A. alternata-positive patient (25 L) was
ncubated with different concentrations (0.2–2000 ng) of purified
ecombinant protein and A. alternata extract separately, overnight
t 4 ◦C. Serum from a D. pteronyssinus-sensitised patient was used
s a control. IgE quantification was performed as described by
awde et al. (2006). Briefly, microtiter plates were pre-coated
ith 50 ng of the purified rAlt a MnSOD diluted in 50 mM pH 9.6
arbonate-bicarbonate buffer. The binding of IgE was  detected by
ouse anti-human IgE-HRP, and the reaction was  developed with
igma-Fast OPD (o-phenylenediamine dihydrochloride). The OD
as measured in a LabSystems Multiskan Bichromatic plate reader
LabSystems, Helsinki, Finland) at 495 nm.
esults
loning  of cDNA coding for A. alternata MnSOD
Full-length Alt a MnSOD cDNA clones were identified using
ACE-PCR, standard cloning techniques and nucleotide sequenc-
ng. The complete cDNA sequence of 748 bp was  submitted to
he GenBank database under accession number KC923297. Alt a
nSOD-encoding cDNA consists of 576 bp, which corresponds to
 deduced amino acid sequence of 191 residues (Fig. 1A). A con-
erved motif, DMWEHAY (142–148 residues), was detected in the
ig. 2. Structural models. (A) Ribbon representation of the Alt a MnSOD monomer. -he
f the Alt a MnSOD tetramer. (C) Alt a MnSOD molecular surface. Identical aminoacids th
hown in blue.cession No. KC923297). The stop codon TAA is shown (*). The manganese and iron
rotein with fungal MnSOD allergens, Asp f 6 from Aspergillus fumigatus and Mala s
 in both A. fumigatus and Alt a MnSOD structures are boxed.
sequence of the deduced protein. A motif search using Gene Runner
software identified this sequence as a manganese and iron super-
oxide dismutase signature. Its theoretical molecular weight was
21.3 kDa, with an isoelectric point of 6.6.
Bioinformatic analysis of the deduced protein sequence
Comparisons of the Alt a MnSOD cDNA sequence with the NCBI
database showed homology with manganese-dependent superox-
ide dismutases from various sources at both the DNA and protein
levels. At the protein level, it was  similar to the MnSODs from
Pyrenophora tritici-repentis (94%) XP 001937231.1, Leptosphaeria
maculans (90%) XP 003842884.1, and Curvularia lunata (89%)
AAQ87929.1. Further, it also showed significant homology with
two fungal allergens in the SDAP database, namely Asp f 6 from
A. fumigatus (59%, e-score: 7e-80) AAB60779 and Mala s 11 from M.
sympodialis (48%, e-score: 2e-57) CAD68071, and two non-fungal
allergens, Hev b 10 from Hevea brasiliensis (45%, e-score: 8e-34)
CAB53458 and Pis v 4 from Pistacia vera (45%, e-score: 4e-33)
EF470980.
Molecular modelling of Alt a MnSOD and identification of putative
cross-reactive IgE-binding epitopes
Sequence alignment revealed that Alt a MnSOD shares signifi-
cant sequence homology with MnSODs from A. fumigatus and M.
sympodialis, two important fungal allergens (Fig. 1B). In all known
MnSOD structures, the metal ion is bound by four invariant protein
ligands: one aspartate and three histidines. In fact, the conserved
amino acids include the three histidines at positions 4, 52 and 146
and the aspartate at position 142 in the Alt a MnSOD  sequence,
which are involved in the binding of Mn2+ metal.
lices are shown in red,  sheets in green and turns in yellow. (B) Ribbon diagram
at are solvent-exposed (FSASA > 0.3) in both Asp f 6 and Alt a MnSOD models are
79
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Fig. 3. Expression of Alt a MnSOD. Lane M – molecular mass marker, Lane 1 –
































Results of allergen-specific IgE detection in serum samples from A. alternata-
sensitised  patients (1–61), a subject mono-sensitised to D. pteronyssinus (62) and
patients with diagnosed ABPA (63–64).
Serum I.d. ImmunoCap sIgE (kU/L) Immunoblotting sIgE
Asp f 6 Alt a 1 Alt a 14
1 0 >100 −
2 0 >100 −
3 0.55 78.2 +
4 0 0 −
5 0 6.39 −
6 0 15.2 −
7 0 11.1 −
8  0 44.2 −
9 0 64.3 −
10 0 4.29 −
11 0 66.4 −
12 0 0 −
13 0 19 −
14 0 4.32 −
15 0 7.24 −
16 0 3.42 −
17 0 3.85 −
18 0 0 −
19 0 10.1 −
20 0 13.6 −
21 0.44 33.7 +
22 0 9.21 −
23  0.46 36 +
24 0 3.84 −
25 0 1.97 +
26 0.37 1.58 +
27 0 0 −
28 0 18.5 −
29 0 1.58 −
30  0 20.1 −
31 0 8.75 −
32 0 >100 −
33 0 34.5 −
34 0 3.03 −
35 0 9.68 −
36 0 15.7 −
37 0 19 −
38 0 36.5 −
39 0 0 −
40 0 24.2 −
41 0 17 −
42 0 1.55 −
43 0 96 −
44 0 13.1 −
45 0 0 −
46 0 0 −
47 0 10.4 −
48 0 7.37 −
49 0 73.4 −
50 0 30 −
51 0 >100 −
52 0 13.7 −
53 0 0 −
54 0 11.3 −
55 0 3.62 −
56 0 4.66 −
57 0 97.1 −
58 0 35 −
59 12.8 0.76 +
60 1.04 0.59 +
61 0 7.89 −
62 0 0 −nclusion bodies fraction. Arrow indicates position of recombinant Alt a MnSOD
and  identified by MALDI, Lane 3 – rAlt a MnSOD purified by Ni-NTA resin, Lane 4 –
nti-His Western Blotting.
A three-dimensional structural model of Alt a MnSOD was gen-
rated using the previously solved crystal structure of Asp f 6
Fluckiger et al., 2002). Model data are available in the PMDB
atabase under the accession number PM0079554. The monomer
xhibits an / fold (Fig. 2A) in accordance with the 3D structure of
sp f 6. Based on the oligomeric state of the template, the tetrameric
tate of the target molecule was created (Fig. 2B).
To  determine which of the residues shared by Asp f 6 and Alt
 MnSOD could be critical for cross-reactivity, conserved residues
hat are exposed to the solvent on the surface of the molecular
odels were identified. It was observed that although Asp f 6 and
lt a MnSOD share 59% of the primary amino acid sequence, only 17
f the pairwise conserved residues, shown in boxes in Fig. 1B, were
t least 30% exposed to the solvent in both models. As shown in
ig. 2C, these critical residues are scattered over the entire surface
f the Alt a MnSOD molecule.
xpression  of recombinant A. alternata MnSOD in E. coli
The  coding region of the isolated cDNA was fused with a short
NA sequence encoding an extra peptide containing a V5 epitope
nd a [His]6-tag at the C-terminus of the protein. Alt a MnSOD
ecombinant protein was expressed in E. coli TOP 10, and it was
etected, recovered and purified from the inclusion body fraction. It
resented an apparent molecular mass of approximately 26 kDa, as
stimated by SDS-PAGE and western blotting with an anti-histidine
ntibody (Fig. 3). The MALDI results showed that MnSODs from
yrenophora teres f. teres and P. tritici-repentis are the closest homo-
ogues of the recombinant protein produced in this study.
uman  IgE recognition of the recombinant proteinThe levels of sIgE to Alt a 1 and Asp f 6 in the 64 study serum
amples measured by ImmunoCAP are shown in Table 1. Among the
1 serum samples from A. alternata-sensitised patients (patients no.
8063 5.11 0 +
64 3.20 0 +
1–61), 54 had Alt a 1 sIgE, and only 6 presented detectable rAsp f 6
sIgE.
Investigation of the IgE reactivity of rAlt a MnSOD  by
immunoblotting revealed that 7 out of 61 A. alternata-sensitised
patient sera reacted with the recombinant molecule (Fig. 4). Thus,
M.F. Gabriel et al. / Immunobiology 220 (2015) 851–858 855






















ig. 4. IgE-immunoblot of rAlt a MnSOD using 64 selected serum samples. Blotted 
ane  62 – serum from a subject sensitised to D. pteronyssinus, Lanes 63–64 – probed
ll sera from A. alternata-sensitised patients containing sIgE to rAsp
 6 (Table 1) labelled the rAlt a MnSOD protein (Fig. 4, patients/lanes
, 21, 23, 26, 59, and 60). Additionally, rAlt a MnSOD was able to
ind IgE from ABPA individuals (patients 63 and 64) who presented
Aspf 6 sIgE.
Immunoblotting inhibition was assayed using serum from
atient no. 59. The inhibition of sera with A. alternata and A. fumi-
atus extracts resulted in an evident inhibition of the protein band
t 26 kDa (Fig. 5A). Furthermore, the ELISA results (Fig. 5B) showed
hat IgE binding of patient number 59s serum to Alt a MnSOD could
e inhibited in a dose-dependent manner by preincubation with
ncreasing amounts of the purified rAlt a MnSOD or the A. alternata
ycelial extract.
Alt  a MnSOD was submitted to the International Union of
mmunological Societies Allergen Nomenclature Sub-Committee
http://www.allergen.org/Allergen.aspx) and was  officially named
lt a 14.
iscussion
Apparent sensitisation to multiple fungi, caused by co-
ensitisation and/or cross-reactivity, represents a frequent clinical
bservation in patients with mould allergy that makes an accu-
ate diagnosis of mould allergy difficult (Crameri et al., 2009). In
ecent years, component-resolved diagnosis has been presented asMnSOD probed with: Lanes 1–61 – individual A. alternata-sensitised patientsı́  sera,
 sera from patients with ABPA.
a valuable tool to discriminate between cases of co-sensitisation
and/or cross-reactivity (Mothes et al., 2006; Vieira et al., 2012).
To improve the molecular diagnosis, the identification and char-
acterisation of all clinically relevant allergens, including both
species-specific and cross-reacting proteins, is required. With this
in mind, in the present work, we aimed to characterise the recently
identified A. alternata Asp f 6 homologue (Alt a 14) and to demon-
strate that it is an A. alternata clinically relevant allergen showing
cross-reactivity with Asp f 6.
The strategy used in this work takes advantage of the similar-
ity of the different fungal MnSOD nucleotide sequences submitted
to the GenBank database, which allowed the design of degener-
ate oligonucleotides and the cloning of Alt a 14-encoding cDNA by
RACE experiments. A sequence similarity search revealed that Alt
a 14 presents high homology with MnSODs from other members
of Pleosporales (P. tritici-repentis (94%), L. maculans (90%), and C.
lunata (89%)). The percent identity decreased when Alt a 14 and
homologous molecules from fungi belonging to other orders were
compared. Significant homology with the allergens contained in
the official list, Asp f 6 (59%), Mala s 11 (48%), Hev b 10 (45%)
and Pis v 4 (45%), was  also detected. Additionally, comparison
between the multiple sequence alignments and the surface acces-
sibility of conserved amino acids in the 3D models of Alt a 14 and
Asp f 6 indicated that although the majority of the residues are
identical, only seventeen are at least 30% solvent exposed in both
81
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Fig. 5. (A) Inhibition of the IgE-immunoblot reactivity of a serum sample that has shown positive reactivity to rAlt a 14. Strips represent results of immunoblot obtained





























xtract and (d) A. fumigatus cellular extract. (B) Inhibition of IgE-binding to recomb
reincubated with increasing amounts of recombinant Alt a 14 and A. alternata extr
tructures and therefore likely to be accessible for interactions with
ross-reactive antibodies. These residues appear scattered over the
ntire surface of the Alt a 14 molecule, suggesting that the entire
urface is potentially cross-reactive with Asp f 6. The exposed
mino acids, either alone or together with surrounding residues,
re likely to define cross-reactive conformational B cell epitopes
hared between Alt a 14 and Asp f 6 and possibly among MnSODs
rom other species. In this regard, based on the solvent-exposed
mino acid distribution profile in the 3D structure, two  regions
ncluding the residues K21, E25, T29 and Q57 and the residues P73,
88, E91 and K161 could be defined as potential cross-reactive
reas. Both areas are present in at least two different sections of
he tetramer surface, satisfying the requirement needed to induce
he cross-linking of allergen-specific IgE bound to the surface of
ffector cells.
The  recombinant production of Alt a 14 was performed in E. coli
nd revealed an apparent molecular mass of 26 kDa. Assessment
f the allergenic significance of Alt a 14 in A. alternata-sensitised
ndividuals  by immunoblotting showed that 11.5% had sIgE to the
6 kDa band, suggesting that Alt a 14 is an A. alternata minor aller-
en. The results of immunoblotting and ELISA inhibition showed
hat native Alt a 14 contained in the A. alternata extracts strongly
nhibited the reaction between rAlt a 14 and the sIgE of an Alt a
4-sensitised patient’s serum, suggesting that the allergenic ability
f the native Alt a 14 is also present in the recombinant polypep-
ide.
Data obtained from the investigation of sIgE to single fungal
llergens, including Alt a 1, Alt a 14 and Asp f 6, revealed that
82 Alt a 14 coated on the solid phase. Serum from an Alt a 14-sensitised patient was
among  the A. alternata-sensitised individuals (n = 61), 86.9% were
sensitised to Alt a 1, 11.5% to Alt a 14 and 9.8% to Asp f 6. Thus,
only one individual who  was sensitised to Alt a 14 was not sensi-
tised to Asp f 6 (Table 1). To explore the potential cross-reactivity
between Alt a 14 and the recognised clinically relevant A. fumiga-
tus allergen Asp f 6, two sera from patients with diagnosed ABPA
and detectable Asp f 6-sIgE were tested by immunoblotting. This
assay demonstrated that both sera recognised rAlt a 14. This finding,
together with the results obtained from immunoblotting-inhibition
assays  using A. fumigatus extract suggest that both allergens possess
allergen-cross-reactive IgE epitopes.
The evidence of cross-reactivity between Alt a 14 and Asp f 6,
demonstrated for the first time in this study, raises some questions
because of the recognised importance of Asp f 6 in allergic diseases
to moulds. In fact, Asp f 6 is regarded, together with Asp f 4, as a
specific marker for ABPA (Fricker-Hidalgo et al., 2010; Hemmann
et al., 1999). Currently, ABPA is associated with an array of immune
responses to A. fumigatus and has been reported to occur primarily
in asthmatic individuals and in patients suffering from cystic fibro-
sis (Knutsen and Slavin, 2011; Baxter et al., 2013). In this regard,
and based on the recognised fact that most A. alternata-sensitised
patients are asthmatic and the recent revelation that A. alternata
contains an allergen that is homologous and cross-reactive to Asp
f 6, it will be important to determine whether Alt a 14-sensitised
individuals are at risk of ABPA. Interestingly, this is in line with
the findings of Jubin et al. (2010), who demonstrated that ABPA
was significantly associated with a prior or concomitant sensitisa-
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isk factor for ABPA. The existence of cross-reactive proteins from
lternaria and Aspergillus species, such as the MnSOD described
n this study, could explain a similar mechanism of sensitisation
hat may  contribute to the pathogenesis of ABPA. Considering the
esults reported by Agarwal et al. (2012, 2013) the possibility that
he individuals who presented positive levels of anti-Asp f 6 and/or
lt a 14 IgE, are in an asymptomatic phase of ABPA with controlled
sthma, stage 0 of ABPA, must not be excluded. For this reason,
hey should be evaluated for ABPA to aid in the early diagnosis
f the disorder before the onset of bronchiectasis. Furthermore,
n the clinical practice, it is not unusual to find patients who
resent negative skin-pick test results to an A. fumigatus extract
ut a positive Asp f 6-specific IgE serum levels. The sensitisation
o the Asp f 6-like from A. alternata, Alt a 14, may  explain this
bservation.
In conclusion, this study characterised Alt a 14 as a minor aller-
en of A. alternata that can trigger a cross-reactive IgE response to
sp f 6. The data disclosed by this study suggest that the Asp f 6-like
llergen found in A. alternata may  be related to ABPA and should
reatly contribute to improving the accuracy of the diagnosis and,
ubsequently, the understanding and management of IgE-mediated
ungal diseases.
atabases
GenBank: nucleotide sequence data are available in the GenBank
atabase under the accession number KC923297.
PMDB: model data are available in the PMDB database under the
ccession number PM0079554.
Allergen database: this new allergen has been submitted,
ccepted and assigned with an official name by the International
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http://www.allergen.org).
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We report a case of a 38-year-old mold-allergic patient who developed episodes of generalized urticaria
and systemic anaphylactic shock immediately after ingesting button mushrooms. A manganese-depen-
dent superoxide dismutase (MnSOD) and a NADP-dependent mannitol dehydrogenase (MtDH) from
Agaricus bisporus mushroom were identified as patient-specific IgE-binding proteins. Cross-reactivity
between A. bisporus MnSOD and mold aeroallergens was confirmed. We conclude that prior sensitization
to mold aeroallergens might explain severe food reactions to cross-reacting homologs mushroom pro-
teins.
& 2015 Published by Elsevier B.V. on behalf of International Society for Human and Animal Mycology.
This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Fungi are recognized as one of the principal causes of type I
allergies, which lead to severe respiratory and cutaneous allergic
diseases [1, 2]. Exposure to fungal allergens can occur by inhala-
tion of mold spores, skin contact with saprophytic species or in-
gestion of edible mushrooms [3]. The most important known al-
lergenic fungi are molds belonging to the genera Alternaria, As-
pergillus and Cladosporium [4]. An association between sensitiza-
tion to airborne molds and systemic reactions caused by ingestion
of mushrooms have been suggested but not extensively in-
vestigated [5, 6]. Among edible mushroom species, Agaricus bis-
porus is the most extensively cultivated and consumed throughout
the world [7].
Here, we describe a case of a woman with bronchial asthma
who experienced episodes of urticaria and anaphylaxis after in-
gesting a button mushroom. The allergens implicated were iden-
tified using the patient's serum.2. Case
A 38-year-old woman was referred because she developed
generalized urticaria immediately after ingesting chicken withlf of International Society for Hum
d/4.0/).
z).mushrooms. One month later and a few minutes after the intake of
fried champignon mushrooms, she suffered an episode of ana-
phylaxis, which needed treatment in the Emergency Department.
She had a previous history of perennial childhood asthma
treated with immunotherapy to Alternaria alternata. Seven years
before food allergy reaction to mushroom, this patient revealed
positive skin prick tests (SPT) to Alternaria, Penicillium, Aspergillus,
dog, mites and grass pollen. Specific IgE tests were positive for
Aspergillus (RAST class 3), Penicillium (RAST class 3) and mites
(RAST class 2). During recent years, she has been stable without
asthma exacerbations, and only minimal medication with anti-
asthmatic drugs has been necessary.
Currently, she related oral itching after the ingestion of several
fruits belonging to the family Rosaceae, and she was tolerant of
banana and tropical fruits (pineapple or mango).
Serum from the patient was obtained with a written consent
agreeing to participate in the study.
After the anaphylactic episode, SPT to commercially available
common inhalants (ALK-Abello SA, Madrid, Spain) were positive
for airborne molds (A. alternata, Cladosporium herbarum, Peni-
cillium notatum and Aspergillus fumigatus) but negative for other
common inhalants, including mite, dander and pollens. SPT using
extracts of Pleurotus ostreatus, Lentinus edodes, Boletus edulis and A.
bisporus (Bial-Aristegui SA, Spain) were also positive. Total serum
IgE was 271 kU/L. Specific IgE by Fluoro Enzyme ImmunoAssay
(ImmunoCAP, Thermo-scientific, Sweden) to the different species
and allergens gave the following results (kU/L): A. alternata, 3.7;an and Animal Mycology. This is an open access article under the CC BY-NC-ND
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Fig. 1. (A) Two-dimensional electrophoresis and (B) Two-dimensional IgE-immunoblotting of Agaricus bisporus crude extract. Immunoblotting was performed using the
patient's serum. (C) Proteins identified by liquid chromatographic electron spray ionization tandem mass spectrometric analysis. MW, molecular weight, pI, isoelectric point.
Table 1
Homologies of Agaricus bisporus manganese-dependent superoxide dismutase and
NADP-dependent mannitol dehydrogenase protein sequences with officially re-
cognized WHO/IUIS mold allergens.
Allergen Source Accession number Swis-
sprot/NCBI/PIR
% Identity E score
Manganese-dependent superoxide dismutases
Asp f 6 Aspergillus fumigatus Q92450 49 8e61
Alt a 14 Alternaria alternata AGS80276 43 1e40
NADP-dependent mannitol dehydrogenase
Alt a 8 Alternaria alternata P0C0Y4 36 9e47




ImmunoCAP inhibition assay results. Recombinant Prup 3 and Asp f 6 were used in
the solid phase and different concentrations of Agaricus bisporus as liquid phase
inhibitor.
M.F. Gabriel et al. / Medical Mycology Case Reports 8 (2015) 14–16 15A. bisporus, 2.1; P. ostreatus, 1.2; L. edodes, 0.5; B. edulis, o0.35;
rAsp f 6, 2.3 and Pru p 3, 20.4. Component-resolved diagnosis
using the ISAC method revealed the following specific IgE results
(ISU): rAlt a 1, 1.3; rAsp f 3, 2.0; rAsp f 6, 2.9 and nPru p 3, 14.
Two dimensional electrophoresis IgE immunoblotting revealed
two spots with apparent molecular weights of approximately 24
and 27 kDa and approximated pIs of 5.2 and 3.2, respectively
(Fig. 1). Both protein spots were excised and identified by liquid
chromatography coupled to mass spectrometry as a manganese-
dependent superoxide dismutase (MnSOD) and NADP-dependent
mannitol dehydrogenase (MtDH) with significantly high scores
(Fig. 1C).
BLAST alignment between MnSOD and MtDH protein se-
quences from A. bisporus (GenBank accession nos. Q9P4T6 and
AAC79985, respectively) and fungal aeroallergen homologs re-
vealed significant homologies (Table 1).
ImmunoCap-inhibition results demonstrated that the A. bis-
porus crude extract was able to strongly inhibit IgE-binding to rAsp
f 6 (68%) but not to rPru p 3 (Table 2).Inhibitor concentrations (A. bis-
porus crude extract) (mg/ml)
% of inhibition (rPru
p 3 in solid-phase)







1.0 0 683. Discussion
Strong allergic reactions to mushrooms have been increasingly
recognized [8–10], and there are few studies reporting an asso-
ciation between aeroallergens and mushroom ingestion-related
symptoms. In this regard, Herrera et al. in some of their works
found a relationship between allergenicity to airborne molds98
M.F. Gabriel et al. / Medical Mycology Case Reports 8 (2015) 14–1616(A. alternata, C. herbarum and A. fumigatus) and food allergies to A.
bisporus mushrooms and spinach, demonstrating the existence of
some non-identified cross-reacting proteins [6–11]. Another study
attributed one form of oral allergy syndrome in adults to heat
labile mushroom proteins of 43–67 kDa in size that also seem
cross-react to molds [5]. In fact, knowledge of allergenic proteins
that cause recognized clinically relevant cross-reactions between
molds and food is still limited, and research in this field is needed
to identify the causative allergens and to understand the im-
munological events that take place.
In this work, we describe a case of a patient with a previous
clinical history of respiratory symptoms associated with mold
aeroallergens and treated by immunotherapy with A. alternata
extract. Years later, this patient suffered anaphylactic shock after
intake of mushrooms. IgE-mediated sensitization to A. alternata, C.
herbarum, P. notatum, A. fumigatus, A. bisporus, P. ostreatus, and L.
edodes was confirmed, and circulating IgE levels reactive to Alt a 1,
Asp f 3, Asp f 6 and Pru p 3 were detected. Moreover, two IgE-
binding components from A. bisporus were identified as a MnSOD
and a MtDH. To date, six MnSODs have been identified and offi-
cially recognized as allergens in A. alternata, A. fumigatus, Hevea
brasiliensis, Olea europaea, Malassezia sympodialis and Pistacia vera,
whereas only two MtDH from A. alternata and C. herbarum are
listed in the WHO/IUIS allergen database (www.allergen.org). Al-
though both families of proteins are described as important cross-
reactive allergens [1–12], cross-reactivity between MnSODs from
different sources has been more intensively studied and reported
[13–15].
Looking at the specific IgE levels, skin prick test results, and the
course of development of allergic symptoms in this patient, it is
assumed that her mushroom-related symptoms could be due to
cross-reactive IgE initially raised against airborne mold homolog
allergens. However, because this patient also reported symptoms
to several fruits belonging to Rosaceae, probably because of cross-
reactive non-specific lipid transfer protein (LTP)-specific IgE anti-
bodies, a relationship between LTP sensitization and allergy to
mushrooms was also not excluded. With this in mind, to de-
termine whether immunologic phenomenon that originated in
systemic reactions upon ingestion of A. bisporus were due to the
presence of cross-reacting antibodies to MnSODs or LTPs, IgE-in-
hibition assays using Asp f 6 and Pru p 3 in the solid-phase were
performed. Blast alignment and inhibition assay results suggest
that the A. bisporus MnSOD homolog has some common epitopes
causing cross-reactivity between mushrooms and common air-
borne molds.
In conclusion, our findings suggest that at least the cross-re-
active A. bisporus MnSOD may lead to severe food allergic reaction
in mold-sensitized patients, justifying the well-recognized re-
lationship between sensitization to airborne molds and allergy to
mushrooms ingestion. However, more in-depth knowledge of the
role of MnSOD and MtDH as causal agents of severe food reactions
is necessary to improve diagnosis and to allow effective avoidance
and prevention of further systemic reactions.Conflict of interest
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Concluding remarks  
 
Compared to other common environmental allergenic sources, fungi are reported as 
neglected and underestimated. Among fungi associated with allergenic diseases, A. alternata 
produces a broad panel of allergenic proteins that may impact the immune system of atopic 
patients, frequently resulting in severe respiratory manifestations. Research on the array of 
allergenic components from A. alternata, prediction of cross-reactivities and the role of these 
proteins in the development of respiratory allergies seem to be very relevant keys in 
establishing correlations between A. alternata exposure and allergic symptoms as well as 
understanding how and why A. alternata is associated with a wide range of serious respiratory 
symptoms. Taking this into account, the studies included in this doctoral work were focused 
on broadening knowledge on A. alternata allergen repertoire, analyzing how these allergens 
are phylogenetically distributed across other allergological important fungal sources and 
determining how they may be employed to justify the complex IgE binding patterns and 
clinical manifestations exhibited by patients sensitized to A. alternata. 
In accordance with previous reports, from a phylogenetic perspective, it was demonstrated 
that the gene encoding for the A. alternata major allergen, Alt a 1, is limited to a restrict 
number of Alternaria related species, exclusively belonging to the Pleosploraceae family. 
Species that are able to produce homologues of this important fungal allergen are also 
potentially capable of stimulating the immune system of atopic patients. Two PCR-based 
systems targeting the detection of the variant and invariant regions of the gene that encodes 
Alt a 1 and Alt a 1 homologues were successfully developed. Results of such assays supported 
that the Alt a 1 gene is a specie-specific molecular marker that may be used as a valuable 
tool in assessing Alt a 1 exposure levels and contamination/colonization by A. alternata and 
other Alt a 1-producing species. This approach constitutes a faster, simpler and optimal 
alternative tool to the traditional species-level identification. Moreover, in this way it is 
possible to establish a relationship between exposure to Alt a 1, independent of its fungal 
origin, and the risk of respiratory symptoms as well as to provide information on the 
implementation of the appropriate public health measures. 
To complete the identification of the allergen panel triggering allergic reactions to A. 
alternata and the understanding of poly-sensitization clinical data were the major goals of 
our research. Taking into account the recent identification of a manganese-dependent 
superoxide dismutase as an IgE reactive component of A. alternata, and the fact that serine 
proteases are well recognized fungal pan-allergens that had never been characterized in A. 
alternata, we intended to proceed to the analysis of the potential of these two A. alternata 
proteins in diagnosis of mold allergy. Since both MnSOD and SP are evolutionarily conserved 
proteins, a combinatorial strategy involving sequence similarity analysis, RACE-PCR and 




obtained sequences were deposited in the GenBank database and are now publicly available. 
The recombinant A. alternata MnSOD and SP were produced and they were shown to bind to 
specific IgE from 11.5% (n=61) and 10.2% (n=59), respectively, of the patients diagnosed as 
being sensitized to A. alternata included in the study. These two new minor A. alternata 
allergens were approved by the WHO/IUIS Allergen Nomenclature Sub-Commitee. 
Consequently, they were added to the panel of A. alternata allergens and were officially 
named Alt a 14 (A. alternata MnSOD) and Alt a 15 (A. alternata SP). The observation that 
both recombinant proteins exhibited similar immunochemical properties for sIgE antibodies to 
the respective counterpart found in the crude extract suggests that the produced 
polypeptides could be used as efficient diagnostic reagents. This work also provided evidence 
that Alt a 14 and Alt a 15 show IgE cross-reactivity with similar homologue allergens from 
other allergological important fungal species, such as A. fumigatus and C. lunata, 
respectively. In addition to allergenicity and cross-reactivity evidences, both new allergens 
seem to play important roles in the development of particular allergic responses. In fact, for 
Alt a 14 we detected that it was able to bind sIgE from ABPA diagnosed patients suggesting 
that sensitivity to this allergen may be related to ABPM. On the other hand, sensitivity to Alt 
a 15 was shown to be highly specific to fungi poly-sensitized patients and appeared to explain 
A. alternata allergy in some cases of patients who did not presented reactivity to the genuine 
sensitization marker, Alt a 1. 
Lastly, in this doctoral work, a strong allergic reaction to mushrooms was found to be 
attributed to two IgE-binding proteins from the mushroom A. bisporus, a MtDH and a MnSOD 
which present their homologues in some airborne molds, including A. alternata. Patient 
clinical history of respiratory allergic symptoms associated to mold aeroallergens, together 
with evidences of cross-reactivity mediated at least by MnSODs, supported the theory that 
environmental mold allergens could act as primary sensitizers’ agents for homologue food 
allergens and lead to severe food allergic reaction. Moreover, this study reveals that although 
they are characterized as minor allergens, the newly identified cross-reactive allergenic 
proteins, namely Alt a 14, may have serious clinical implications and may be used in clinical 
practice as a prognostic marker of potential systemic reaction to mushrooms. 
Overall, the findings achieved in this doctoral research work allowed for the consideration of 
new perspectives for improving the accuracy of the assessment of allergen exposure, 





Future Trends  
 
Due to the fact that fungal allergy continues to be a poorly studied area both in basic 
research as well as in clinical practice, there is substantial room for improvement. In this 
regard, the results presented in this doctoral thesis have not only contributed to a significant 
increase in the understanding of this area of study, but have also paved the way for future 
investigations: 
 In order to prove its value in monitoring the exposure to Alt a 1 allergen, the simple, 
sensitive and specific PCR system that was developed and presented in this work, 
should be applied in epidemiological studies using environmental air/dust and food 
samples. This will allow establishing potential correlations of allergic manifestations 
with Alt a 1 exposure levels existing in the environment surrounding atopic patients 
and provide information on the implementation of appropriated personal/public 
protective health measures. 
 
 The molecular studies performed in this work have also supported the theory that 
evolutionary events have conditioned the profile of mold components that are 
recognized by the human’s immune system resulting in a complex range of allergic 
manifestations. Thus, also based in recent reports which strengthen the same 
hypothesis, additional phylogenic studies should be performed in order to correlate 
the evolutionary process of the genes coding for allergen, its potential role in fungal 
biology and allergic response. 
 
 The produced recombinant proteins may be applied in improving molecular diagnosis 
allowing for the definition of individual IgE reactivity patterns, mainly in fungal poly-
sensitized population and information of prognosis of clinical manifestations and 
potential cross-reactivities. This may also lead to a more effective specific 
immunotherapy using a single or a few allergenic molecules.  
 
 The availability of the recombinant A. alternata allergens may also be applied in 
studies with animal models in order to elucidate the biological role of A. alternata in 
the physiopathogenesis of allergy and asthma. 
 
 Given the apparent association between sensitization to Alt a 14 and ABPA verified in 
this work, asthmatic patients presenting IgE reactivity to Alt a 14 should be 
extensively evaluated to ascertain if they are at risk of developing ABPM or if they are 





 Since proteolytic active serine proteases are described as potent adjuvant of 
inflammatory response in allergy and asthma, Alt a 15 should be produced in its 









Appendix  A - Sequence data of the gene encoding for Alt a 14 available from the GenBank. 
 
Appendix  B - Sequence data of the gene encoding for Alt a 15 available from the GenBank. 
 
Appendix  C - Alt a 14 allergen information from the WHO/IUIS Allergen Nomenclature    
Database. 
 











ALLERGEN NOMENCLATURE  










Username or Email:  Password:  
Login  
Allergen Details:
Allergen name: Alt a 14 
Lineage:
Source: Fungi Ascomycota 
Order: Pleosporales 
Species: Alternaria alternata (Alternaria rot fungus) 
Biochemical name: Manganese superoxide dismutase
MW(SDS-PAGE): 24 kDa (reducing)
Allergenicity ref.: 21255138
Food allergen: No
Date Created: 2014-02-19 07:45:08
Last Updated: 2014-02-19 07:57:57
Submitter Info:
Name: Marta F. Gabriel






+/- Isoallergen and variants GenBank Nucleotide GenBank Protein UniProt PDB
Alt a 14.0101 KC923297 AGS80276 P86254  
Fungi Ascomycota Pleosporales Alternaria alternata Alt a 14
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Username or Email:  Password:  
Login  
Allergen Details:
Allergen name: Alt a 15 
Lineage:
Source: Fungi Ascomycota 
Order: Pleosporales 
Species: Alternaria alternata (Alternaria rot fungus) 
Biochemical name: Serine protease
MW(SDS-PAGE): 58 kD
Allergenicity: Three of 53 mold-sensitized subjects had IgE+ binding in reducing immunoblot presented at EAACI as poster in Milan, 2013.
Food allergen: No
Date Created: 2014-11-11 14:36:16
Last Updated: 2014-11-11 14:36:16
Submitter Info:
Name: Marta F. Gabriel






+/- Isoallergen and variants GenBank Nucleotide GenBank Protein UniProt PDB
Alt a 15.0101 KJ558435 (To be released upon publication)    
Fungi Ascomycota Pleosporales Alternaria alternata Alt a 15
Page 1 of 1Alt a 15 Allergen Details
02/06/2015http://www.allergen.org/viewallergen.php?aid=820
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